BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Becker RC. COVID-19 update: Covid-19-associated coagulopathy. J Thromb Thrombolysis 2020;50:54-67. [PMID: 32415579 DOI: 10.1007/s11239-020-02134-3] [Cited by in Crossref: 222] [Cited by in F6Publishing: 298] [Article Influence: 111.0] [Reference Citation Analysis]
Number Citing Articles
1 Roy B, Runa SA. SARS-CoV-2 infection and diabetes: Pathophysiological mechanism of multi-system organ failure. World J Virol 2022; 11(5): 252-274 [DOI: 10.5501/wjv.v11.i5.252] [Reference Citation Analysis]
2 Cunningham RM, Johnson Moore KL, Moore JS. Coagulopathy during COVID-19 infection: a brief review. Clin Exp Med 2022. [PMID: 36121504 DOI: 10.1007/s10238-022-00891-4] [Reference Citation Analysis]
3 Del Vecchio S, Terlizzi C, Pellegrino S, Altobelli GG, Fonti R. What molecular imaging of cancer patients can teach us about COVID-19. Eur Phys J Plus 2022;137. [DOI: 10.1140/epjp/s13360-022-03262-w] [Reference Citation Analysis]
4 Feltgen N, Ach T, Ziemssen F, Quante CS, Gross O, Abdin AD, Aisenbrey S, Bartram MC, Blum M, Brockmann C, Dithmar S, Friedrichs W, Guthoff R, Hattenbach L, Herrlinger KR, Kaskel-paul S, Khoramnia R, Klaas JE, Krohne TU, Lommatzsch A, Lueken S, Maier M, Nassri L, Nguyen-dang TA, Radeck V, Rau S, Roider J, Sandner D, Schmalenberger L, Schmidtmann I, Schubert F, Siegel H, Spitzer MS, Stahl A, Stingl JV, Treumer F, Viestenz A, Wachtlin J, Wolf A, Zimmermann J, Schargus M, Schuster AK. Retinal Vascular Occlusion after COVID-19 Vaccination: More Coincidence than Causal Relationship? Data from a Retrospective Multicentre Study. JCM 2022;11:5101. [DOI: 10.3390/jcm11175101] [Reference Citation Analysis]
5 Tudoran C, Velimirovici DE, Berceanu-vaduva DM, Rada M, Voiţă-mekeres F, Tudoran M. Increased Susceptibility for Thromboembolic Events versus High Bleeding Risk Associated with COVID-19. Microorganisms 2022;10:1738. [DOI: 10.3390/microorganisms10091738] [Reference Citation Analysis]
6 Heubner L, Greiner M, Vicent O, Beyer-Westendorf J, Tiebel O, Scholz U, Güldner A, Mirus M, Fries D, Koch T, Spieth PM. Predictive ability of viscoelastic testing using ClotPro® for short-term outcome in patients with severe Covid-19 ARDS with or without ECMO therapy: a retrospective study. Thromb J 2022;20:48. [PMID: 36038895 DOI: 10.1186/s12959-022-00403-0] [Reference Citation Analysis]
7 Välikangas T, Junttila S, Rytkönen KT, Kukkonen-macchi A, Suomi T, Elo LL. COVID-19-specific transcriptomic signature detectable in blood across multiple cohorts. Front Genet 2022;13:929887. [DOI: 10.3389/fgene.2022.929887] [Reference Citation Analysis]
8 Zhang H, Lao Q, Zhang J, Zhu J. Coagulopathy in COVID-19 and anticoagulation clinical trials. Best Practice & Research Clinical Haematology 2022. [DOI: 10.1016/j.beha.2022.101377] [Reference Citation Analysis]
9 LaVasseur C, Neukam S, Kartika T, Samuelson Bannow B, Shatzel J, DeLoughery TG. Hormonal therapies and venous thrombosis: Considerations for prevention and management. Res Pract Thromb Haemost 2022;6:e12763. [PMID: 36032216 DOI: 10.1002/rth2.12763] [Reference Citation Analysis]
10 Novaes N, Sadik R, Sadik JC, Obadia M. Epidemiology and Management of Cerebral Venous Thrombosis during the COVID-19 Pandemic. Life (Basel) 2022;12:1105. [PMID: 35892907 DOI: 10.3390/life12081105] [Reference Citation Analysis]
11 Lee LE, Jeong W, Park YB, Jeong SJ, Lee SW. Clinical Significance of Antineutrophil Cytoplasmic Antibody Positivity in Patients Infected with SARS-CoV-2. J Clin Med 2022;11:4152. [PMID: 35887916 DOI: 10.3390/jcm11144152] [Reference Citation Analysis]
12 Hakmi H, Islam S, Petrone P, Sajan A, Baltazar G, Sohail AH, Goulet N, Jacquez R, Stright A, Velcu L, Divers J, Joseph DK. COVID-19 and the injured patient: A multicenter review. Journal of Surgical Research 2022. [DOI: 10.1016/j.jss.2022.06.068] [Reference Citation Analysis]
13 B DJ. Historical aspects and current understanding of the connections and implications of viruses and diabetes: A narrative review. Clinical Epidemiology and Global Health 2022;16:101110. [DOI: 10.1016/j.cegh.2022.101110] [Reference Citation Analysis]
14 Pillay-fuentes Lorente V, Van Rensburg R, Moolla MS, Mccaul M, Parker A, Taljaard J, Reuter H, Decloedt EH. Bleeding and thrombosis outcomes in hospitalised COVID-19 patients on low-molecular-weight heparin and antiplatelet therapy. S Afr Med J 2022. [DOI: 10.7196/samj.2022.v112i7.16434] [Reference Citation Analysis]
15 Omer S, Gondal MF, Usman M, Sarwar MB, Roman M, Khan A, Afzal N, Qaiser TA, Yasir M, Shahzad F, Tahir R, Ayub S, Akram J, Faizan RM, Naveed MA, Jahan S. Epidemiology, Clinico-Pathological Characteristics, and Comorbidities of SARS-CoV-2-Infected Pakistani Patients. Front Cell Infect Microbiol 2022;12:800511. [PMID: 35755851 DOI: 10.3389/fcimb.2022.800511] [Reference Citation Analysis]
16 Zaini M, Abu Farha R, Abutayeh R, Alsaud W, Hammoudeh A, Al-shudifat A, Al-kharabsheh T. Assessment of Jordanian physicians’ knowledge about venous thromboembolism risk and management among COVID-19 patients. Journal of Pharmaceutical Health Services Research 2022. [DOI: 10.1093/jphsr/rmac021] [Reference Citation Analysis]
17 Vojdani A, Vojdani E, Rosenberg AZ, Shoenfeld Y. The Role of Exposomes in the Pathophysiology of Autoimmune Diseases II: Pathogens. Pathophysiology 2022;29:243-80. [DOI: 10.3390/pathophysiology29020020] [Reference Citation Analysis]
18 Johnston AB, Choudhri AF, Inoa V, Ditta LC. Vision Preservation in COVID-Related Cerebral Sinovenous Thrombosis With Optic Nerve Sheath Fenestration. J Neuroophthalmol 2022;42:e463-5. [PMID: 35006654 DOI: 10.1097/WNO.0000000000001304] [Reference Citation Analysis]
19 Rajendran R, Chathambath A, Al-Sehemi AG, Pannipara M, Unnikrishnan MK, Aleya L, Raghavan RP, Mathew B. Critical role of nitric oxide in impeding COVID-19 transmission and prevention: a promising possibility. Environ Sci Pollut Res Int 2022;29:38657-72. [PMID: 35258738 DOI: 10.1007/s11356-022-19148-4] [Reference Citation Analysis]
20 Ramírez-Martínez G, Jiménez-Álvarez LA, Cruz-Lagunas A, Ignacio-Cortés S, Gómez-García IA, Rodríguez-Reyna TS, Choreño-Parra JA, Zúñiga J. Possible Role of Matrix Metalloproteinases and TGF-β in COVID-19 Severity and Sequelae. J Interferon Cytokine Res 2022. [PMID: 35647937 DOI: 10.1089/jir.2021.0222] [Reference Citation Analysis]
21 Anwar MM, Sah R, Shrestha S, Ozaki A, Roy N, Fathah Z, Rodriguez-Morales AJ. Disengaging the COVID-19 Clutch as a Discerning Eye Over the Inflammatory Circuit During SARS-CoV-2 Infection. Inflammation 2022. [PMID: 35639261 DOI: 10.1007/s10753-022-01674-5] [Reference Citation Analysis]
22 Liana P, Liberty IA, Murti K, Hafy Z, Salim EM, Zulkarnain M, Umar TP. A systematic review on neutrophil extracellular traps and its prognostication role in COVID-19 patients. Immunol Res 2022. [PMID: 35604493 DOI: 10.1007/s12026-022-09293-w] [Reference Citation Analysis]
23 Zhang Q, Cannavicci A, Kutryk MJB, Mandraffino G. Exploring Endothelial Colony-Forming Cells to Better Understand the Pathophysiology of Disease: An Updated Review. Stem Cells International 2022;2022:1-14. [DOI: 10.1155/2022/4460041] [Reference Citation Analysis]
24 Saibaba J, Selvaraj J, Viswanathan S, Pillai V. Scrub Typhus and COVID-19 Coinfection Unmasking Antiphospholipid Antibody Syndrome. Cureus. [DOI: 10.7759/cureus.25008] [Reference Citation Analysis]
25 Niculae C, Anghel A, Militaru E, Tîrlescu L, Lazar M, Hristea A. Acute Pulmonary Artery Thrombosis despite Anticoagulation in Patients with COVID-19 Pneumonia: A Single-Center Retrospective Cohort Study. JCM 2022;11:2633. [DOI: 10.3390/jcm11092633] [Reference Citation Analysis]
26 Duhailib ZA, Oczkowski S, Polok K, Fronczek J, Szczeklik W, Piticaru J, Mammen MJ, Alshamsi F, Eikelboom J, Belley-cote EP, Alhazzani W. Venous and Arterial Thrombosis in COVID-19: An updated Narrative Review. Journal of Infection and Public Health 2022. [DOI: 10.1016/j.jiph.2022.05.003] [Reference Citation Analysis]
27 Yamashita Y, Yachi S, Takeyama M, Nishimoto Y, Tsujino I, Nakamura J, Yamamoto N, Nakata H, Ikeda S, Umetsu M, Aikawa S, Hayashi H, Satokawa H, Okuno Y, Iwata E, Ogihara Y, Ikeda N, Kondo A, Iwai T, Yamada N, Ogawa T, Kobayashi T, Mo M. Influence of sex on development of thrombosis in patients with COVID-19: From the CLOT-COVID study. Thrombosis Research 2022;213:173-8. [DOI: 10.1016/j.thromres.2022.03.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
28 Soma T, Fujii K, Yoshifuji A, Maruki T, Itoh K, Taniyama D, Kikuchi T, Hasegawa N, Nakamura M. Nafamostat mesylate monotherapy in patients with moderate COVID-19 : A single-center retrospective study. Jpn J Infect Dis. [DOI: 10.7883/yoken.jjid.2021.699] [Reference Citation Analysis]
29 Cervantes-arslanian AM, Venkata C, Anand P, Burns JD, Ong CJ, Lemahieu AM, Schulte PJ, Singh TD, Rabinstein AA, Deo N, Bansal V, Boman K, Domecq Garces JP, Lee Armaignac D, Christie AB, Melamed RR, Tarabichi Y, Cheruku SR, Khanna AK, Denson JL, Banner-goodspeed VM, Anderson HL, Gajic O, Kumar VK, Walkey A, Kashyap R; on behalf of the Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry Investigator Group. Neurologic Manifestations of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Hospitalized Patients During the First Year of the COVID-19 Pandemic. Critical Care Explorations 2022;4:e0686. [DOI: 10.1097/cce.0000000000000686] [Reference Citation Analysis]
30 Akpolat C, Cetinkaya T, Kurt MM. A Pediatric COVID-19 Study: Retinal Nerve Fiber Layer, Ganglion Cell Layer, and Alterations in Choroidal Thickness in Swept-Source OCT Measurements. Klin Monbl Augenheilkd. [DOI: 10.1055/a-1785-3863] [Reference Citation Analysis]
31 Cetinkaya T, Kurt MM, Cetinkaya H, Akpolat C. Analysis of Microvasculature in Children Recovered from COVID-19 Using Swept-Source OCT/OCTA Technology. Ocular Immunology and Inflammation. [DOI: 10.1080/09273948.2022.2054431] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Hess CN, Capell WH, Bristow MR, Ruf W, Szarek M, Morrow DA, Nicolau JC, Graybill CA, Marshall D, Hsia J, Bonaca MP. Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trial. Am Heart J 2022;246:136-43. [PMID: 34986394 DOI: 10.1016/j.ahj.2021.12.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
33 Hingorani KS, Bhadola S, Cervantes-arslanian AM. COVID-19 and the Brain. Trends in Cardiovascular Medicine 2022. [DOI: 10.1016/j.tcm.2022.04.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
34 Challa AP, Hu X, Zhang YQ, Hymes J, Wallace BD, Karavadhi S, Sun H, Patnaik S, Hall MD, Shen M. Virtual Screening for the Discovery of Microbiome β-Glucuronidase Inhibitors to Alleviate Cancer Drug Toxicity. J Chem Inf Model 2022. [PMID: 35357819 DOI: 10.1021/acs.jcim.1c01414] [Reference Citation Analysis]
35 Hoepler W, Traugott M, Zoufaly A, Schatzl M, Hind J, Wenisch C, Neuhold S. [Diagnosis and treatment of COVID-19 in intensive care units]. Med Klin Intensivmed Notfmed 2022. [PMID: 35347341 DOI: 10.1007/s00063-022-00909-5] [Reference Citation Analysis]
36 Babajani A, Moeinabadi-Bidgoli K, Niknejad F, Rismanchi H, Shafiee S, Shariatzadeh S, Jamshidi E, Farjoo MH, Niknejad H. Human placenta-derived amniotic epithelial cells as a new therapeutic hope for COVID-19-associated acute respiratory distress syndrome (ARDS) and systemic inflammation. Stem Cell Res Ther 2022;13:126. [PMID: 35337387 DOI: 10.1186/s13287-022-02794-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Malagoli A, Rossi L, Zanni A, Muto F, Tosetti A, Tondi S. Sustained right ventricular dysfunction in severe COVID-19: The role of disseminated intravascular coagulation. Echocardiography 2022. [PMID: 35277886 DOI: 10.1111/echo.15332] [Reference Citation Analysis]
38 Visser C, Biedermann JS, Nierman MC, van der Meer FJM, Gulpen AJW, Moors YCF, Cannegieter SC, Lijfering WM, Kruip MJHA; Dutch COVID & Thrombosis Coalition. The Immediate Effect of COVID-19 Vaccination on Anticoagulation Control in Patients Using Vitamin K Antagonists. Thromb Haemost 2022;122:377-85. [PMID: 35245945 DOI: 10.1055/s-0042-1742628] [Reference Citation Analysis]
39 Flumignan RL, Civile VT, Tinôco JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah ÁN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev 2022;3:CD013739. [PMID: 35244208 DOI: 10.1002/14651858.CD013739.pub2] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
40 Karabulut Uzuncakmak S, Dirican E, Naldan M, Kesmez Can F, Halıcı Z. Investigation of CYP2E1 and Caspase-3 Gene Expressions in COVID-19 patients. Gene Reports 2022;26:101497. [DOI: 10.1016/j.genrep.2022.101497] [Reference Citation Analysis]
41 Larrea J, Villota-deleu E, Fernández-vega B, Fernández-vega Sanz Á. Late retinal and optic nerve vascular complications due to COVID-19 in young individuals. American Journal of Ophthalmology Case Reports 2022;25:101327. [DOI: 10.1016/j.ajoc.2022.101327] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Guddeti RR, Yildiz M, Nayak KR, Alraies MC, Davidson L, Henry TD, Garcia S. Impact of COVID-19 on Acute Myocardial Infarction Care. Cardiology Clinics 2022. [DOI: 10.1016/j.ccl.2022.03.004] [Reference Citation Analysis]
43 Scheim DE. A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at Its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and Antibody. Int J Mol Sci 2022;23:2558. [PMID: 35269703 DOI: 10.3390/ijms23052558] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
44 Premeaux TA, Yeung ST, Bukhari Z, Bowler S, Alpan O, Gupta R, Ndhlovu LC. Emerging Insights on Caspases in COVID-19 Pathogenesis, Sequelae, and Directed Therapies. Front Immunol 2022;13:842740. [DOI: 10.3389/fimmu.2022.842740] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Arabi M, Heidari Beigvand H, Samimagham H, Salimi N, Kazemi Jahromi M. Upper Limb Ischemia Following COVID-19 Infection: A Case Report. Jundishapur J Microbiol 2022;15. [DOI: 10.5812/jjm.122074] [Reference Citation Analysis]
46 Bursi F, Santangelo G, Barbieri A, Vella AM, Toriello F, Valli F, Sansalone D, Carugo S, Guazzi M. Impact of Right Ventricular‐Pulmonary Circulation Coupling on Mortality in SARS‐CoV‐2 Infection. JAHA. [DOI: 10.1161/jaha.121.023220] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 O'Donovan C, Vyas N, Ghanchi F. Retinal Vein Occlusion with COVID-19: A Case Report and Review of Literature. Ocul Immunol Inflamm 2022;:1-5. [PMID: 35119981 DOI: 10.1080/09273948.2022.2032196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Fan BE, Chia YW, Lim GH, Bok CF, Wong SW. Global haemostatic tests demonstrate the absence of parameters of hypercoagulability in non-hypoxic mild COVID-19 patients: a prospective matched study-Reply to comment from Muzaffar et al. J Thromb Thrombolysis 2022. [PMID: 35113293 DOI: 10.1007/s11239-022-02636-2] [Reference Citation Analysis]
49 Pisoschi AM, Pop A, Iordache F, Stanca L, Geicu OI, Bilteanu L, Serban AI. Antioxidant, anti-inflammatory and immunomodulatory roles of vitamins in COVID-19 therapy. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114175] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
50 Chen AT, Wang CY, Zhu WL, Chen W. Coagulation Disorders and Thrombosis in COVID-19 Patients and a Possible Mechanism Involving Endothelial Cells: A Review. Aging Dis 2022;13:144-56. [PMID: 35111367 DOI: 10.14336/AD.2021.0704] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
51 Aires RB, Soares AASM, Gomides APM, Nicola AM, Teixeira-Carvalho A, da Silva DLM, de Gois ET, Xavier FD, Martins FP, Santos GPJ, Schulte HL, Luz IS, Espindola LS, do Amaral LR, Felicori LF, Naves LA, de Carvalho MRM, Gomes MS, Nóbrega OT, Albuquerque P, Fontes W, Gomes CM, Kurizky PS, Albuquerque CP, Martins-Filho OA, da Mota LMH. Thromboelastometry demonstrates endogenous coagulation activation in nonsevere and severe COVID-19 patients and has applicability as a decision algorithm for intervention. PLoS One 2022;17:e0262600. [PMID: 35030224 DOI: 10.1371/journal.pone.0262600] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
52 Marvi TK, Stubblefield WB, Tillman BF, Tenforde MW, Patel MM, Lindsell CJ, Self WH, Grijalva CG, Rice TW; for the Influenza and Other Viruses in the Acutely Ill (IVY) Network. Serial Thromboelastography and the Development of Venous Thromboembolism in Critically Ill Patients With COVID-19. Critical Care Explorations 2022;4:e0618. [DOI: 10.1097/cce.0000000000000618] [Reference Citation Analysis]
53 Wong K, Farooq Alam Shah MU, Khurshid M, Ullah I, Tahir MJ, Yousaf Z. COVID-19 associated vasculitis: A systematic review of case reports and case series. Ann Med Surg (Lond) 2022;:103249. [PMID: 35039779 DOI: 10.1016/j.amsu.2022.103249] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
54 Golabchi K, Rezaee A, Aghadoost D, Hashemipour M. Anterior ischemic optic neuropathy as a rare manifestation of COVID-19: a case report. Future Virology. [DOI: 10.2217/fvl-2021-0068] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Schoene D, Schnekenberg LG, Pallesen LP, Barlinn J, Puetz V, Barlinn K, Siepmann T. Pathophysiology of Cardiac Injury in COVID-19 Patients with Acute Ischaemic Stroke: What Do We Know So Far?-A Review of the Current Literature. Life (Basel) 2022;12:75. [PMID: 35054468 DOI: 10.3390/life12010075] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Plassmeyer M, Alpan O, Corley MJ, Premeaux TA, Lillard K, Coatney P, Vaziri T, Michalsky S, Pang APS, Bukhari Z, Yeung ST, Evering TH, Naughton G, Latterich M, Mudd P, Spada A, Rindone N, Loizou D, Ulrik Sønder S, Ndhlovu LC, Gupta R. Caspases and therapeutic potential of caspase inhibitors in moderate-severe SARS-CoV-2 infection and long COVID. Allergy 2022;77:118-29. [PMID: 33993490 DOI: 10.1111/all.14907] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
57 López-Jaime FJ, Fernández-Bello I, Martín-Téllez S, Doblas-Márquez A, Tesfay Y, Márquez-Gómez I, Reguera-Iglesias JM, Muñoz-Pérez MI, Montaño A. Clot Stiffness Measured By Seer Sonorheometry As a Marker Of Poor Prognosis In Hospitalized COVID-19 Patients. Clin Appl Thromb Hemost 2022;28:10760296221112085. [PMID: 35903939 DOI: 10.1177/10760296221112085] [Reference Citation Analysis]
58 da Silva-Neto PV, de Carvalho JCS, Pimentel VE, Pérez MM, Toro DM, Fraga-Silva TFC, Fuzo CA, Oliveira CNS, Rodrigues LC, Argolo JGM, Carmona-Garcia I, Neto NT, Souza COS, Fernandes TM, Bastos VAF, Degiovani AM, Constant LF, Ostini FM, Feitosa MR, Parra RS, Vilar FC, Gaspar GG, da Rocha JJR, Feres O, Frantz FG, Gerlach RF, Maruyama SR, Russo EMS, Viana AL, Fernandes APM, Santos IKFM, Bonato VLD, Boechat AL, Malheiro A, Sadikot RT, Dias-Baruffi M, Cardoso CRB, Faccioli LH, Sorgi CA, On Behalf Of The Imunocovid Study Group. sTREM-1 Predicts Disease Severity and Mortality in COVID-19 Patients: Involvement of Peripheral Blood Leukocytes and MMP-8 Activity. Viruses 2021;13:2521. [PMID: 34960790 DOI: 10.3390/v13122521] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
59 Nugroho J, Wardhana A, Rachmi DA, Mulia EPB, A'yun MQ, Septianda I, Maghfirah IB. Simple Coagulation Profile as Predictor of Mortality in Adults Admitted with COVID-19: A Meta-Analysis. Arch Clin Infect Dis 2021;16. [DOI: 10.5812/archcid.115442] [Reference Citation Analysis]
60 Castillo-Perez M, Jerjes-Sanchez C, Castro-Varela A, Paredes-Vazquez JG, Vazquez-Garza E, Ramos-Cazares RE, Salinas-Casanova JA, Molina-Rodriguez AM, Martinez-Ibarra AA, Fabiani MA, Flores-Sayavedra YZ, Guajardo-Lozano JA, Lopez-de la Garza H, Betancourt-Del Campo H, Martinez-Magallanes D, Panneflek J. Differences between surviving and non-surviving venous thromboembolism COVID-19 patients: a systematic review. Thromb J 2021;19:101. [PMID: 34911551 DOI: 10.1186/s12959-021-00346-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
61 Grave C, Gabet A, Empana JP, Puymirat E, Tuppin P, Danchin N, Olié V. Care management and 90-day post discharge mortality in patients hospitalized for myocardial infarction and COVID-19: A French nationwide observational study. Arch Cardiovasc Dis 2021:S1875-2136(21)00219-9. [PMID: 34952827 DOI: 10.1016/j.acvd.2021.11.002] [Reference Citation Analysis]
62 Fernández-Lázaro D, Sánchez-Serrano N, Mielgo-Ayuso J, García-Hernández JL, González-Bernal JJ, Seco-Calvo J. Long COVID a New Derivative in the Chaos of SARS-CoV-2 Infection: The Emergent Pandemic? J Clin Med 2021;10:5799. [PMID: 34945095 DOI: 10.3390/jcm10245799] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
63 Putilina MV, Teplova NV, Bairova KI, Petrikeeva AE, Shabalina NI. [The result of prospective randomized study CITADEL - the efficacy and safety of drug cytoflavin in postcovid rehabilitation]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:45-51. [PMID: 34874654 DOI: 10.17116/jnevro202112110145] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
64 Cetinkaya T, Kurt MM, Akpolat C. Analysis of swept-source optical coherence tomography angiography measurement alterations in adult patients recovered from COVID-19. Clin Exp Optom 2021;:1-5. [PMID: 34875203 DOI: 10.1080/08164622.2021.1999770] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
65 Ilyas S, Henkin S, Martinez-Camblor P, Suckow BD, Beach JM, Stone DH, Goodney PP, Ebinger JE, Creager MA, Columbo JA. Sex-, Race- and Ethnicity-Based Differences in Thromboembolic Events Among Adults Hospitalized With COVID-19. J Am Heart Assoc 2021;10:e022829. [PMID: 34845920 DOI: 10.1161/JAHA.121.022829] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
66 Gündoğan M, Vural E, Bayram N, Altunel O, Gündoğan F, Göktaş S. Change in retinal vessel diameter and choroidal thickness in patients with severe COVID-19: Change In Retinal Parameters In Patients With Severe COVID-19. Photodiagnosis Photodyn Ther 2021;37:102674. [PMID: 34879296 DOI: 10.1016/j.pdpdt.2021.102674] [Reference Citation Analysis]
67 Helin TA, Lemponen M, Lahtiharju T, Koskinen M, Lassila R, Joutsi-Korhonen L. Anaemia and enhancement of coagulation are associated with severe COVID-19 infection. Scand J Clin Lab Invest 2021;:1-8. [PMID: 34793272 DOI: 10.1080/00365513.2021.2001845] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
68 Neuenfeldt FS, Weigand MA, Fischer D. Coagulopathies in Intensive Care Medicine: Balancing Act between Thrombosis and Bleeding. J Clin Med 2021;10:5369. [PMID: 34830667 DOI: 10.3390/jcm10225369] [Reference Citation Analysis]
69 Jiang Y, Duffy F, Hadlock J, Raappana A, Styrchak S, Beck I, Mast FD, Miller LR, Chour W, Houck J, Armistead B, Duvvuri VR, Yeung W, Haglund M, Wallner J, Wallick JA, Hardy S, Oldroyd A, Ko D, Gervassi A, Murray KM, Kaplan H, Aitchison JD, Heath JR, Sather DN, Goldman JD, Frenkel L, Harrington WE. Angiotensin II receptor I auto-antibodies following SARS-CoV-2 infection. PLoS One 2021;16:e0259902. [PMID: 34788328 DOI: 10.1371/journal.pone.0259902] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
70 Thapa K, Verma N, Singh TG, Kaur Grewal A, Kanojia N, Rani L. COVID-19-Associated acute respiratory distress syndrome (CARDS): Mechanistic insights on therapeutic intervention and emerging trends. Int Immunopharmacol 2021;101:108328. [PMID: 34768236 DOI: 10.1016/j.intimp.2021.108328] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
71 Larijani B, Foroughi-Heravani N, Abedi M, Tayanloo-Beik A, Rezaei-Tavirani M, Adibi H, Arjmand B. Recent Advances of COVID-19 Modeling Based on Regenerative Medicine. Front Cell Dev Biol 2021;9:683619. [PMID: 34760882 DOI: 10.3389/fcell.2021.683619] [Reference Citation Analysis]
72 Asili P, Mirahmad M, Tabatabaei-Malazy O, Manayi A, Haghighat E, Mahdavi M, Larijani B. Characteristics of published/registered clinical trials on COVID-19 treatment: A systematic review. Daru 2021;29:449-67. [PMID: 34762250 DOI: 10.1007/s40199-021-00422-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 Hautecloque G, Kempf C, Stan C, Arentz-Dugay MH, Vuillemet F, Ahle G, Sellal F, Martinot M. Multifocal and Microvascular Involvement in Ischemic Stroke During COVID-19: A Cohort Study With Comparison With Non-COVID-19 Stroke. Front Neurol 2021;12:732194. [PMID: 34759880 DOI: 10.3389/fneur.2021.732194] [Reference Citation Analysis]
74 Bertini M, D'Aniello E, Di Ienno L, Gibiino F, Tavazzi G, Volta CA, Contoli M, Papi A, Campo G, Ferrari R, Rapezzi C. Phenotypic heterogeneity of COVID-19 pneumonia: clinical and pathophysiological relevance of the vascular phenotypea. ESC Heart Fail 2021. [PMID: 34755468 DOI: 10.1002/ehf2.13602] [Reference Citation Analysis]
75 Neethling C, Calligaro G, Miller M, Opie JJS. The evolution of clot strength in critically-ill COVID-19 patients: a prospective observational thromboelastography study. Thromb J 2021;19:83. [PMID: 34742307 DOI: 10.1186/s12959-021-00331-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
76 Shafiee MA, Hosseini SF, Mortazavi M, Emami A, Mojtahed Zadeh M, Moradi S, Shaker P. Anticoagulation therapy in COVID-19 patients with chronic kidney disease. J Res Med Sci 2021;26:63. [PMID: 34729071 DOI: 10.4103/jrms.JRMS_875_20] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
77 Zureigat H, Alhusban M, Cobia M. Mechanical Thrombectomy Outcomes in COVID-19 Patients With Acute Ischemic Stroke: A Narrative Review. Neurologist 2021;26:261-7. [PMID: 34734904 DOI: 10.1097/NRL.0000000000000360] [Reference Citation Analysis]
78 Lippi G, Szergyuk I, de Oliveira MHS, Benoit SW, Benoit JL, Favaloro EJ, Henry BM. The role of lipoprotein(a) in coronavirus disease 2019 (COVID-19) with relation to development of severe acute kidney injury. J Thromb Thrombolysis 2021. [PMID: 34709533 DOI: 10.1007/s11239-021-02597-y] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
79 Rando HM, MacLean AL, Lee AJ, Lordan R, Ray S, Bansal V, Skelly AN, Sell E, Dziak JJ, Shinholster L, D'Agostino McGowan L, Ben Guebila M, Wellhausen N, Knyazev S, Boca SM, Capone S, Qi Y, Park Y, Mai D, Sun Y, Boerckel JD, Brueffer C, Byrd JB, Kamil JP, Wang J, Velazquez R, Szeto GL, Barton JP, Goel RR, Mangul S, Lubiana T, Gitter A, Greene CS; COVID-19 Review Consortium Vikas Bansal, John P. Barton, Simina M. Boca, Joel D. Boerckel, Christian Brueffer, James Brian Byrd, Stephen Capone, Shikta Das, Anna Ada Dattoli, John J. Dziak, Jeffrey M. Field, Soumita Ghosh, Anthony Gitter, Rishi Raj Goel, Casey S. Greene, Marouen Ben Guebila, Daniel S. Himmelstein, Fengling Hu, Nafisa M. Jadavji, Jeremy P. Kamil, Sergey Knyazev, Likhitha Kolla, Alexandra J. Lee, Ronan Lordan, Tiago Lubiana, Temitayo Lukan, Adam L. MacLean, David Mai, Serghei Mangul, David Manheim, Lucy D’Agostino McGowan, Amruta Naik, YoSon Park, Dimitri Perrin, Yanjun Qi, Diane N. Rafizadeh, Bharath Ramsundar, Halie M. Rando, Sandipan Ray, Michael P. Robson, Vincent Rubinetti, Elizabeth Sell, Lamonica Shinholster, Ashwin N. Skelly, Yuchen Sun, Yusha Sun, Gregory L. Szeto, Ryan Velazquez, Jinhui Wang, Nils Wellhausen, . Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure. mSystems 2021;6:e0009521. [PMID: 34698547 DOI: 10.1128/mSystems.00095-21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
80 Elyaspour Z, Zibaeenezhad MJ, Razmkhah M, Razeghian-Jahromi I. Is It All About Endothelial Dysfunction and Thrombosis Formation? The Secret of COVID-19. Clin Appl Thromb Hemost 2021;27:10760296211042940. [PMID: 34693754 DOI: 10.1177/10760296211042940] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
81 Tang X, Zheng F. A review of ischemic stroke in COVID-19: currently known pathophysiological mechanisms. Neurol Sci 2021. [PMID: 34671854 DOI: 10.1007/s10072-021-05679-0] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
82 Purkayastha P, Iftikhar MJ, Kostrubiec M. Ventricular Septal Defect in Delayed Presentation of ST-Elevation Myocardial Infarction (STEMI) Secondary to COVID-19 Pandemic. Cureus 2021;13:e17913. [PMID: 34660108 DOI: 10.7759/cureus.17913] [Reference Citation Analysis]
83 Ullah I, Sohail A, Shah MUFA, Khurshid M, Diwan MN, Qadir A, Irfan M. Central Retinal Vein Occlusion in patients with COVID-19 infection: A systematic review. Ann Med Surg (Lond) 2021;71:102898. [PMID: 34659743 DOI: 10.1016/j.amsu.2021.102898] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
84 Santosa YP, Yuwono A. Two Different Clinical Presentations of Acute Limb Ischemia Caused by Acute Thrombotic Events in COVID-19. Cureus 2021;13:e17916. [PMID: 34660110 DOI: 10.7759/cureus.17916] [Reference Citation Analysis]
85 Ai J, Hong W, Wu M, Wei X. Pulmonary vascular system: A vulnerable target for COVID-19. MedComm (2020) 2021. [PMID: 34909758 DOI: 10.1002/mco2.94] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Lamponi S. Bioactive Natural Compounds with Antiplatelet and Anticoagulant Activity and Their Potential Role in the Treatment of Thrombotic Disorders. Life (Basel) 2021;11:1095. [PMID: 34685464 DOI: 10.3390/life11101095] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
87 Erdem S, Karahan M, Ava S, Dursun ME, Dursun B, Hazar L, Bozarslan Senol B, Keklikci U. Evaluation of choroidal thickness in patients who have recovered from COVID-19. Int Ophthalmol 2021. [PMID: 34611768 DOI: 10.1007/s10792-021-02049-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
88 Jacobi J. The pathophysiology of sepsis-2021 update: Part 1, immunology and coagulopathy leading to endothelial injury. Am J Health Syst Pharm 2021:zxab380. [PMID: 34605875 DOI: 10.1093/ajhp/zxab380] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
89 Choudhary S, Sharma K, Singh PK. Von Willebrand factor: A key glycoprotein involved in thrombo-inflammatory complications of COVID-19. Chem Biol Interact 2021;348:109657. [PMID: 34516971 DOI: 10.1016/j.cbi.2021.109657] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
90 Güler T, Yurdakul FG, Acar Sivas F, Kiliç Z, Adigüzel E, Yaşar E, Bodur H. Rehabilitative management of post-acute COVID-19: clinical pictures and outcomes. Rheumatol Int 2021;41:2167-75. [PMID: 34580754 DOI: 10.1007/s00296-021-05003-1] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
91 Fan BE, Ramanathan K, Sum CLL, Christopher D, Chan SSW, Lim GH, Bok CF, Wong SW, Lye DC, Young BE, Lim JY, Lee RM, Lim SP, Tan HT, Ang MK, Lau SL, Kuperan P, Ong KH, Chia YW. Global haemostatic tests demonstrate the absence of parameters of hypercoagulability in non-hypoxic mild COVID-19 patients: a prospective matched study. J Thromb Thrombolysis 2021. [PMID: 34581945 DOI: 10.1007/s11239-021-02575-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
92 Ambereen A, Rahman SA, Rehman S, Zaidi K, Arif SH. Mandibular mucormycosis following SARS-CoV-2 infection - A case report and review of literature. Clin Infect Pract 2021;12:100099. [PMID: 34568807 DOI: 10.1016/j.clinpr.2021.100099] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
93 Tomerak S, Khan S, Almasri M, Hussein R, Abdelati A, Aly A, Salameh MA, Saed Aldien A, Naveed H, Elshazly MB, Zakaria D. Systemic inflammation in COVID‐19 patients may induce various types of venous and arterial thrombosis: A systematic review. Scand J Immunol 2021;94. [DOI: 10.1111/sji.13097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
94 Battina HL, Alentado VJ, Srour EF, Moliterno AR, Kacena MA. Interaction of the inflammatory response and megakaryocytes in COVID-19 infection. Exp Hematol 2021:S0301-472X(21)00328-3. [PMID: 34563606 DOI: 10.1016/j.exphem.2021.09.005] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
95 Khismatullin RR, Ponomareva AA, Nagaswami C, Ivaeva RA, Montone KT, Weisel JW, Litvinov RI. Pathology of lung-specific thrombosis and inflammation in COVID-19. J Thromb Haemost 2021. [PMID: 34538029 DOI: 10.1111/jth.15532] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
96 Naqvi AR, Schwartz J, Brandini DA, Schaller S, Hussein H, Valverde A, Naqvi RA, Shukla D. COVID-19 and oral diseases: Assessing manifestations of a new pathogen in oral infections. Int Rev Immunol 2021;:1-15. [PMID: 34525891 DOI: 10.1080/08830185.2021.1967949] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
97 Basic-Jukic N, Coric M, Bulimbasic S, Dika Z, Juric I, Furic-Cunko V, Katalinic L, Kos J, Fistrek M, Kastelan Z, Jelakovic B. Histopathologic findings on indication renal allograft biopsies after recovery from acute COVID-19. Clin Transplant 2021;:e14486. [PMID: 34532893 DOI: 10.1111/ctr.14486] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
98 Saleh M, Alkofide A, Alshammari A, Siddiqui K, Owaidah T. Changes in Hematological, Clinical and Laboratory Parameters for Children with COVID-19: Single-Center Experience. J Blood Med 2021;12:819-26. [PMID: 34512062 DOI: 10.2147/JBM.S321372] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
99 Shibeeb S, Ahmad MN. Thrombotic and Hypercoagulability Complications of COVID-19: An Update. J Blood Med 2021;12:785-93. [PMID: 34512059 DOI: 10.2147/JBM.S316014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
100 Liu D, Zeng X, Ding Z, Lv F, Mehta JL, Wang X. Adverse Cardiovascular Effects of Anti-COVID-19 Drugs. Front Pharmacol 2021;12:699949. [PMID: 34512335 DOI: 10.3389/fphar.2021.699949] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
101 Al Otair H, AlSaleh K, AlQahtany FS, Al Ayed K, Al Ammar H, Al Mefgai N, Al Zeer F. The Level of vWF Antigen and Coagulation Markers in Hospitalized Patients with Covid-19. J Blood Med 2021;12:809-17. [PMID: 34512061 DOI: 10.2147/JBM.S318940] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
102 Bobescu E, Marceanu LG, Covaciu A, Vladau LA. Thrombosis, an important piece in the COVID-19 puzzle: From pathophysiology to therapy. Anatol J Cardiol 2021;25:601-8. [PMID: 34498590 DOI: 10.5152/AnatolJCardiol.2021.475] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
103 Sharma V, Singh AP, Singh AP. Therapeutic approaches in covid-19 followed before arrival of any vaccine. Mater Today Proc 2021. [PMID: 34493973 DOI: 10.1016/j.matpr.2021.08.265] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
104 Abacioglu OO, Yildirim A. The ATRIA score is superior to the m-CHA2DS2-Vasc score in predicting in-hospital mortality in COVID-19. Rev Assoc Med Bras (1992) 2021;67:443-8. [PMID: 34468612 DOI: 10.1590/1806-9282.20200983] [Reference Citation Analysis]
105 Jonathan GL, Scott FM, Matthew KD. A Case of Post-COVID-19-Associated Paracentral Acute Middle Maculopathy and Giant Cell Arteritis-Like Vasculitis. J Neuroophthalmol 2021;41:351-5. [PMID: 34415268 DOI: 10.1097/WNO.0000000000001348] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
106 Tokarek T, Dziewierz A, Malinowski KP, Rakowski T, Bartuś S, Dudek D, Siudak Z. Treatment Delay and Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction during the COVID-19 Pandemic. J Clin Med 2021;10:3920. [PMID: 34501369 DOI: 10.3390/jcm10173920] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
107 Talebian A, Soltani B, Aghadoost D, Azadbakht J, Rezaee A, Abbasy Z. Association Between Novel Coronavirus Disease 2019 (COVID-19) and Idiopathic Intracranial Hypertension. Arch Pediatr Infect Dis 2021;In Press. [DOI: 10.5812/pedinfect.115171] [Reference Citation Analysis]
108 Burgos-Blasco B, Güemes-Villahoz N, Vidal-Villegas B, Garcia-Feijoo J, Donate-Lopez J, Martin-Sanchez FJ, Gonzalez-Armengol JJ, Mendez-Hernandez CD. Optic Nerve Head Vessel Density Assessment in Recovered COVID-19 Patients: A Prospective Study Using Optical Coherence Tomography Angiography. J Glaucoma 2021;30:711-7. [PMID: 33927148 DOI: 10.1097/IJG.0000000000001858] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
109 Valle EO, Cabrera CPS, Albuquerque CCC, Silva GVD, Oliveira MFA, Sales GTM, Smolentzov I, Reichert BV, Andrade L, Seabra VF, Lins PRG, Rodrigues CE. Continuous renal replacement therapy in COVID-19-associated AKI: adding heparin to citrate to extend filter life-a retrospective cohort study. Crit Care 2021;25:299. [PMID: 34412667 DOI: 10.1186/s13054-021-03729-9] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
110 Sen S, Kannan NB, Kumar J, Rajan RP, Kumar K, Baliga G, Reddy H, Upadhyay A, Ramasamy K. Retinal manifestations in patients with SARS-CoV-2 infection and pathogenetic implications: a systematic review. Int Ophthalmol 2021. [PMID: 34379290 DOI: 10.1007/s10792-021-01996-7] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
111 Becker RC, Sexton T, Smyth S; International COVID-19 Thrombosis Biomarkers Colloquium (ICODE) Investigators. COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesicles. J Thromb Thrombolysis 2021. [PMID: 34350541 DOI: 10.1007/s11239-021-02544-x] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
112 Sullivan KD, Galbraith MD, Kinning KT, Bartsch KW, Levinsky NC, Araya P, Smith KP, Granrath RE, Shaw JR, Baxter RM, Jordan KR, Russell SA, Dzieciatkowska ME, Reisz JA, Gamboni F, Cendali FI, Ghosh T, Monte AA, Bennett TD, Miller MG, Hsieh EW, D'Alessandro A, Hansen KC, Espinosa JM. The COVIDome Explorer researcher portal. Cell Rep 2021;:109527. [PMID: 34348131 DOI: 10.1016/j.celrep.2021.109527] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
113 Motolese F, Ferrante M, Rossi M, Magliozzi A, Sbarra M, Ursini F, Marano M, Capone F, Travaglino F, Antonelli Incalzi R, Di Lazzaro V, Pilato F. Posterior Reversible Encephalopathy Syndrome and brain haemorrhage as COVID-19 complication: a review of the available literature. J Neurol 2021. [PMID: 34291313 DOI: 10.1007/s00415-021-10709-0] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
114 García de Guadiana-Romualdo L, Morell-García D, Favaloro EJ, Vílchez JA, Bauça JM, Alcaide Martín MJ, Gutiérrez Garcia I, de la Hera Cagigal P, Egea-Caparrós JM, Pérez Sanmartín S, Gutiérrez Revilla JI, Urrechaga E, Álamo JM, Hernando Holgado AM, Lorenzo-Lozano MC, Canalda Campás M, Juncos Tobarra MA, Morales-Indiano C, Vírseda Chamorro I, Pastor Murcia Y, Sahuquillo Frías L, Altimira Queral L, Nuez-Zaragoza E, Adell Ruiz de León J, Ruiz Ripa A, Salas Gómez-Pablos P, Cebreiros López I, Fernández Uriarte A, Larruzea A, López Yepes ML, Sancho-Rodríguez N, Zamorano Andrés MC, Pedregosa Díaz J, Sáenz L, Esparza Del Valle C, Baamonde Calzada MC, García Muñoz S, Vera M, Martín Torres E, Sánchez Fdez-Pacheco S, Vicente Gutiérrez L, Jiménez Añón L, Pérez Martínez A, Pons Castillo A, González Tamayo R, Férriz Vivancos J, Rodríguez-Fraga O, Díaz-Brito V, Aguadero V, García Arévalo MG, Arnaldos Carrillo M, González Morales M, Núñez Gárate M, Ruiz Iruela C, Esteban Torrella P, Vila Pérez M, Acevedo Alcaraz C, Blázquez-Manzanera AL, Galán Ortega A. Harmonized D-dimer levels upon admission for prognosis of COVID-19 severity: Results from a Spanish multicenter registry (BIOCOVID-Spain study). J Thromb Thrombolysis 2021. [PMID: 34272635 DOI: 10.1007/s11239-021-02527-y] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
115 Gusev E, Sarapultsev A, Hu D, Chereshnev V. Problems of Pathogenesis and Pathogenetic Therapy of COVID-19 from the Perspective of the General Theory of Pathological Systems (General Pathological Processes). Int J Mol Sci 2021;22:7582. [PMID: 34299201 DOI: 10.3390/ijms22147582] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
116 Sierra-Hidalgo F, Aragón Revilla E, Arranz García P, Martínez-Acebes E, Gómez-Moreno SM, Muñoz-Rivas N, Esquivel López A; Infanta Leonor Thrombosis Research Group. Increased Incidence of In-Hospital Ischemic Stroke During SARS-CoV-2 Outbreak: A Single-Center Study. Neurocrit Care 2021. [PMID: 34268645 DOI: 10.1007/s12028-021-01286-1] [Reference Citation Analysis]
117 Matucci-Cerinic M, Hughes M, Taliani G, Kahaleh B. Similarities between COVID-19 and systemic sclerosis early vasculopathy: A "viral" challenge for future research in scleroderma. Autoimmun Rev 2021;20:102899. [PMID: 34274540 DOI: 10.1016/j.autrev.2021.102899] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
118 Martinot M, Eyriey M, Gravier S, Bonijoly T, Kayser D, Ion C, Mohseni-Zadeh M, Camara S, Dubois J, Haerrel E, Drouaine J, Kaiser J, Ongagna JC, Schieber-Pachart A, Kempf C; Centre Alsace COVID-19 Study Group. Predictors of mortality, ICU hospitalization, and extrapulmonary complications in COVID-19 patients. Infect Dis Now 2021:S2666-9919(21)00425-5. [PMID: 34242842 DOI: 10.1016/j.idnow.2021.07.002] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
119 Ionescu MA. COVID-19 skin lesions are rarely positive at RT-PCR test: the macrophage activation with vascular impact and SARS-CoV-2-induced cytokine storm. Int J Dermatol 2021. [PMID: 34213786 DOI: 10.1111/ijd.15749] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
120 Arslan G. Celiac Artery Thrombosis and Splenic Infarction as a Consequence of Mild COVID-19 Infection: Report of an Unusual Case. Hamostaseologie 2021. [PMID: 34198348 DOI: 10.1055/a-1508-7388] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
121 Putilina MV, Grishin DV. SARS-CoV-2 (COVID-19) as a Predictor of Neuroinflammation and Neurodegeneration: Potential Treatment Strategies. Neurosci Behav Physiol 2021;:1-6. [PMID: 34176996 DOI: 10.1007/s11055-021-01108-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
122 Seth S, Rashid F, Khera K. An overview of the COVID-19 complications in paediatric population: A pandemic dilemma. Int J Clin Pract 2021;75:e14494. [PMID: 34115913 DOI: 10.1111/ijcp.14494] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
123 Hadar E, Dollinger S, Wiznitzer A. Coronavirus disease and vaccination during pregnancy and childbirth: a review of the Israeli perspective and experience. J Matern Fetal Neonatal Med 2021;:1-12. [PMID: 34130586 DOI: 10.1080/14767058.2021.1937110] [Reference Citation Analysis]
124 Pérez-Campos Mayoral L, Hernández-Huerta MT, Papy-García D, Barritault D, Zenteno E, Sánchez Navarro LM, Pérez-Campos Mayoral E, Matias Cervantes CA, Martínez Cruz M, Mayoral Andrade G, López Cervantes M, Vázquez Martínez G, López Sánchez C, Pina Canseco S, Martínez Cruz R, Pérez-Campos E. Immunothrombotic dysregulation in chagas disease and COVID-19: a comparative study of anticoagulation. Mol Cell Biochem 2021;476:3815-25. [PMID: 34110554 DOI: 10.1007/s11010-021-04204-3] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
125 McCafferty C, Van Den Helm S, Letunica N, Attard C, Karlaftis V, Cai T, Praporski S, Swaney E, Burgner D, Neeland M, Dohle K, Crawford NW, Clucas L, Tosif S, Ignjatovic V, Monagle P. Increased platelet activation in SARS-CoV-2 infected non-hospitalised children and adults, and their household contacts. Br J Haematol 2021. [PMID: 34101171 DOI: 10.1111/bjh.17629] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
126 Cancelliere A, Procopio G, Mazzitelli M, Lio E, Petullà M, Serapide F, Pelle MC, Davoli C, Trecarichi EM, Torti C; IDTM UMG COVID‐19 Group. A case report of pneumomediastinum in a COVID-19 patient treated with high-flow nasal cannula and review of the literature: Is this a "spontaneous" complication? Clin Case Rep 2021;9:e04007. [PMID: 34084480 DOI: 10.1002/ccr3.4007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
127 Trigonis RA, Khan BA, Rahman O. The authors reply. Crit Care Med 2021;49:e116-7. [PMID: 33337756 DOI: 10.1097/CCM.0000000000004719] [Reference Citation Analysis]
128 Herrmann J, Notz Q, Schlesinger T, Stumpner J, Kredel M, Sitter M, Schmid B, Kranke P, Schulze H, Meybohm P, Lotz C. Point of care diagnostic of hypercoagulability and platelet function in COVID-19 induced acute respiratory distress syndrome: a retrospective observational study. Thromb J 2021;19:39. [PMID: 34078393 DOI: 10.1186/s12959-021-00293-8] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
129 Chang JC. COVID-19 Sepsis: Pathogenesis and Endothelial Molecular Mechanisms Based on "Two-Path Unifying Theory" of Hemostasis and Endotheliopathy-Associated Vascular Microthrombotic Disease, and Proposed Therapeutic Approach with Antimicrothrombotic Therapy. Vasc Health Risk Manag 2021;17:273-98. [PMID: 34103921 DOI: 10.2147/VHRM.S299357] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
130 De Hous N, Hollering P, Van Looveren R, Tran T, De Roover D, Vercauteren S. Symptomatic arterial thrombosis associated with novel coronavirus disease 2019 (COVID-19): report of two cases. Acta Chir Belg 2021;:1-4. [PMID: 33820491 DOI: 10.1080/00015458.2021.1911751] [Reference Citation Analysis]
131 Tisdale AK, Dinkin M, Chwalisz BK. Afferent and Efferent Neuro-Ophthalmic Complications of Coronavirus Disease 19. J Neuroophthalmol 2021;41:154-65. [PMID: 33935220 DOI: 10.1097/WNO.0000000000001276] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
132 Hall K, Mfone F, Shallcross M, Pathak V. Review of Pharmacotherapy Trialed for Management of the Coronavirus Disease-19. Eurasian J Med 2021;53:137-43. [PMID: 34177298 DOI: 10.5152/eurasianjmed.2021.20384] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
133 Holleb P, Patel P, Saxena P, Beniwal J, Zuberi J. Acute abdomen in a 54-year-old COVID-19 patient: a case teport. J Surg Case Rep 2021;2021:rjab198. [PMID: 34084447 DOI: 10.1093/jscr/rjab198] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
134 Samad N, Dutta S, Sodunke TE, Fairuz A, Sapkota A, Miftah ZF, Jahan I, Sharma P, Abubakar AR, Rowaiye AB, Oli AN, Charan J, Islam S, Haque M. Fat-Soluble Vitamins and the Current Global Pandemic of COVID-19: Evidence-Based Efficacy from Literature Review. J Inflamm Res 2021;14:2091-110. [PMID: 34045883 DOI: 10.2147/JIR.S307333] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
135 Ghosh R, Roy D, Mandal A, Pal SK, Chandra Swaika B, Naga D, Pandit A, Ray BK, Benito-León J. Cerebral venous thrombosis in COVID-19. Diabetes Metab Syndr 2021;15:1039-45. [PMID: 34015627 DOI: 10.1016/j.dsx.2021.04.026] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
136 Moon CY, Schilder BM, Raj T, Huang KL. Phenome-wide and expression quantitative trait locus associations of coronavirus disease 2019 genetic risk loci. iScience 2021;24:102550. [PMID: 34027315 DOI: 10.1016/j.isci.2021.102550] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
137 Jing W, Procko E. ACE2-based decoy receptors for SARS coronavirus 2. Proteins 2021;89:1065-78. [PMID: 33973262 DOI: 10.1002/prot.26140] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
138 Arévalos V, Ortega-Paz L, Rodríguez-Arias JJ, Calvo M, Castrillo L, Salazar A, Roque M, Dantas AP, Sabaté M, Brugaletta S. Myocardial Injury in COVID-19 Patients: Association with Inflammation, Coagulopathy and In-Hospital Prognosis. J Clin Med 2021;10:2096. [PMID: 34068127 DOI: 10.3390/jcm10102096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
139 Sanidas E, Grassos C, Papadopoulos D, Velliou M, Barbetseas J. Pulmonary Embolism Prophylaxis in Patients With COVID-19: An Emerging Issue. Heart Lung Circ 2021:S1443-9506(21)00499-6. [PMID: 34049806 DOI: 10.1016/j.hlc.2021.04.018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
140 Yassin A, Ghzawi A, Al-Mistarehi AH, El-Salem K, Y Benmelouka A, M Sherif A, BenhadjDahman N, AlAdamat N, Jemel A, Negida A, Abdelmonem M. Mortality rate and biomarker expression within COVID-19 patients who develop acute ischemic stroke: a systematic review and meta-analysis. Future Sci OA 2021;7:FSO713. [PMID: 34254031 DOI: 10.2144/fsoa-2021-0036] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
141 Deng H, Tang TX, Chen D, Tang LS, Yang XP, Tang ZH. Endothelial Dysfunction and SARS-CoV-2 Infection: Association and Therapeutic Strategies. Pathogens 2021;10:582. [PMID: 34064553 DOI: 10.3390/pathogens10050582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
142 Hoepel W, Chen HJ, Geyer CE, Allahverdiyeva S, Manz XD, de Taeye SW, Aman J, Mes L, Steenhuis M, Griffith GR, Bonta PI, Brouwer PJM, Caniels TG, van der Straten K, Golebski K, Jonkers RE, Larsen MD, Linty F, Nouta J, van Roomen CPAA, van Baarle FEHP, van Drunen CM, Wolbink G, Vlaar APJ, de Bree GJ, Sanders RW, Willemsen L, Neele AE, van de Beek D, Rispens T, Wuhrer M, Bogaard HJ, van Gils MJ, Vidarsson G, de Winther M, den Dunnen J. High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages. Sci Transl Med 2021;13:eabf8654. [PMID: 33979301 DOI: 10.1126/scitranslmed.abf8654] [Cited by in Crossref: 9] [Cited by in F6Publishing: 55] [Article Influence: 9.0] [Reference Citation Analysis]
143 Bai G, Furushima D, Niki T, Matsuba T, Maeda Y, Takahashi A, Hattori T, Ashino Y. High Levels of the Cleaved Form of Galectin-9 and Osteopontin in the Plasma Are Associated with Inflammatory Markers That Reflect the Severity of COVID-19 Pneumonia. Int J Mol Sci 2021;22:4978. [PMID: 34067072 DOI: 10.3390/ijms22094978] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
144 Lordan R, Rando HM, Greene CS; COVID-19 Review Consortium. Dietary Supplements and Nutraceuticals under Investigation for COVID-19 Prevention and Treatment. mSystems 2021;6:e00122-21. [PMID: 33947804 DOI: 10.1128/mSystems.00122-21] [Cited by in Crossref: 3] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
145 Sahu U, Biswas D, Singh AK, Khare P. Mechanism involved in the pathogenesis and immune response against SARS-CoV-2 infection. Virusdisease 2021;:1-9. [PMID: 33969150 DOI: 10.1007/s13337-021-00687-2] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
146 Kohansal Vajari M, Shirin M, Pourbagheri-Sigaroodi A, Akbari ME, Abolghasemi H, Bashash D. COVID-19-related coagulopathy: A review of pathophysiology and pharmaceutical management. Cell Biol Int 2021. [PMID: 33945651 DOI: 10.1002/cbin.11623] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
147 Krämer A, Billaud JN, Tugendreich S, Shiffman D, Jones M, Green J. The Coronavirus Network Explorer: mining a large-scale knowledge graph for effects of SARS-CoV-2 on host cell function. BMC Bioinformatics 2021;22:229. [PMID: 33941085 DOI: 10.1186/s12859-021-04148-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
148 Beura SK, Panigrahi AR, Yadav P, Singh SK. Phytochemicals as Potential Therapeutics for SARS-CoV-2-Induced Cardiovascular Complications: Thrombosis and Platelet Perspective. Front Pharmacol 2021;12:658273. [PMID: 33981235 DOI: 10.3389/fphar.2021.658273] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
149 Manzoor D, Bui C, Makhoul E, Luthringer D, Marchevsky A, Volod O. Improvement in plasma D-dimer level in severe SARS-CoV-2 infection can be an indicator of fibrinolysis suppression: Case reports. Medicine (Baltimore) 2021;100:e25255. [PMID: 33847623 DOI: 10.1097/MD.0000000000025255] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
150 Pawlos A, Niedzielski M, Gorzelak-Pabiś P, Broncel M, Woźniak E. COVID-19: Direct and Indirect Mechanisms of Statins. Int J Mol Sci 2021;22:4177. [PMID: 33920709 DOI: 10.3390/ijms22084177] [Cited by in Crossref: 4] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
151 Bapaye MM, Nair AG, Bapaye CM, Bapaye MM, Shukla JJ. Simultaneous Bilateral Central Retinal Artery Occlusion following COVID-19 Infection. Ocul Immunol Inflamm 2021;:1-4. [PMID: 33856275 DOI: 10.1080/09273948.2021.1891262] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
152 Henry BM, Szergyuk I, de Oliveira MHS, Abosamak MF, Benoit SW, Benoit JL, Lippi G. Alterations in the lipid profile associate with a dysregulated inflammatory, prothrombotic, anti-fibrinolytic state and development of severe acute kidney injury in coronavirus disease 2019 (COVID-19): A study from Cincinnati, USA. Diabetes Metab Syndr 2021;15:863-8. [PMID: 33878674 DOI: 10.1016/j.dsx.2021.04.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
153 Erdem S, Karahan M, Dursun ME, Ava S, Hazar L, Katran I, Keklikci U. Retinal Vasculitis Case Developing in the Early Period after COVID-19. Klin Monbl Augenheilkd 2021. [PMID: 33853180 DOI: 10.1055/a-1363-1326] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
154 Cetinkaya T, Kurt MM, Akpolat C. Assessment of Retinal Neurodegeneration and Choroidal Thickness in COVID-19 Patients Using Swept-Source OCT Technology. Klin Monbl Augenheilkd 2021. [PMID: 33853186 DOI: 10.1055/a-1340-0066] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
155 Becker K, Beythien G, de Buhr N, Stanelle-Bertram S, Tuku B, Kouassi NM, Beck S, Zickler M, Allnoch L, Gabriel G, von Köckritz-Blickwede M, Baumgärtner W. Vasculitis and Neutrophil Extracellular Traps in Lungs of Golden Syrian Hamsters With SARS-CoV-2. Front Immunol 2021;12:640842. [PMID: 33912167 DOI: 10.3389/fimmu.2021.640842] [Cited by in Crossref: 3] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
156 Saha A, Bajpai A, Krishna V, Bhattacharya S. Evolving Paradigm of Prothrombin Time Diagnostics with Its Growing Clinical Relevance towards Cardio-Compromised and COVID-19 Affected Population. Sensors (Basel) 2021;21:2636. [PMID: 33918646 DOI: 10.3390/s21082636] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
157 Cañas CA, Cañas F, Bautista-Vargas M, Bonilla-Abadía F. Role of Tissue Factor in the Pathogenesis of COVID-19 and the Possible Ways to Inhibit It. Clin Appl Thromb Hemost 2021;27:10760296211003983. [PMID: 33784877 DOI: 10.1177/10760296211003983] [Cited by in Crossref: 3] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
158 Beals J 4th, Barnes JJ, Durand DJ, Rimar JM, Donohue TJ, Hoq SM, Belk KW, Amin AN, Rothman MJ. Stratifying Deterioration Risk by Acuity at Admission Offers Triage Insights for Coronavirus Disease 2019 Patients. Crit Care Explor 2021;3:e0400. [PMID: 33937866 DOI: 10.1097/CCE.0000000000000400] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
159 Kartikasari U, Djajalaksana S, Martini H. Acute limb ischemia in a patient with Covid-19 pneumonia: a case report. J Thromb Thrombolysis 2021. [PMID: 33797021 DOI: 10.1007/s11239-021-02434-2] [Reference Citation Analysis]
160 Ferrari F, Martins VM, Teixeira M, Santos RD, Stein R. COVID-19 and Thromboinflammation: Is There a Role for Statins? Clinics (Sao Paulo) 2021;76:e2518. [PMID: 33787678 DOI: 10.6061/clinics/2021/e2518] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
161 Nugroho J, Wardhana A, Mulia EP, Maghfirah I, Rachmi DA, A'yun MQ, Septianda I. Elevated fibrinogen and fibrin degradation product are associated with poor outcome in COVID-19 patients: A meta-analysis. Clin Hemorheol Microcirc 2021;77:221-31. [PMID: 33074221 DOI: 10.3233/CH-200978] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
162 Wang Z, Du Z, Zhao X, Guo F, Wang T, Zhu F. Determinants of Increased Fibrinogen in COVID-19 Patients With and Without Diabetes and Impaired Fasting Glucose.Clin Appl Thromb Hemost. 2021;27:1076029621996445. [PMID: 33760664 DOI: 10.1177/1076029621996445] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
163 Mohamed M, Smith J, Parajuli S, Garg N, Aziz F, Mandelbrot D, Djamali A, Zhong W. Successful management of T-cell mediated rejection in a recent kidney transplant recipient with COVID-19 associated severe acute respiratory syndrome. Transpl Infect Dis 2021;:e13598. [PMID: 33780103 DOI: 10.1111/tid.13598] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
164 Margaroli C, Benson P, Sharma NS, Madison MC, Robison SW, Arora N, Ton K, Liang Y, Zhang L, Patel RP, Gaggar A. Spatial mapping of SARS-CoV-2 and H1N1 lung injury identifies differential transcriptional signatures. Cell Rep Med 2021;2:100242. [PMID: 33778787 DOI: 10.1016/j.xcrm.2021.100242] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
165 Harris CL, Achuthanandan S, Para K, Shetty V. A Fatal Extrapulmonary Manifestation of COVID-19. Cureus 2021;13:e14068. [PMID: 33903831 DOI: 10.7759/cureus.14068] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
166 Kurian SJ, Unnikrishnan MK, Miraj SS, Bagchi D, Banerjee M, Reddy BS, Rodrigues GS, Manu MK, Saravu K, Mukhopadhyay C, Rao M. Probiotics in Prevention and Treatment of COVID-19: Current Perspective and Future Prospects. Arch Med Res 2021;52:582-94. [PMID: 33785208 DOI: 10.1016/j.arcmed.2021.03.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
167 Bellos I, Tavernaraki K, Stefanidis K, Michalopoulou O, Lourida G, Korompoki E, Thanou I, Thanos L, Pefanis A, Argyraki A. Chest CT severity score and radiological patterns as predictors of disease severity, ICU admission, and viral positivity in COVID-19 patients. Respir Investig 2021;59:436-45. [PMID: 33820751 DOI: 10.1016/j.resinv.2021.02.008] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
168 Hong LZ, Shou ZX, Zheng DM, Jin X. The most important biomarker associated with coagulation and inflammation among COVID-19 patients. Mol Cell Biochem 2021;476:2877-85. [PMID: 33742367 DOI: 10.1007/s11010-021-04122-4] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
169 Sanjay S, Srinivasan P, Jayadev C, Mahendradas P, Gupta A, Kawali A, Shetty R. Post COVID-19 Ophthalmic Manifestations in an Asian Indian Male. Ocul Immunol Inflamm 2021;:1-6. [PMID: 33733987 DOI: 10.1080/09273948.2020.1870147] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
170 Manek G, Gupta M, Congrete S, Datta D. Submassive Pulmonary Embolism in Mild COVID-19 Without Lung Infiltrates. Cureus 2021;13:e13978. [PMID: 33880305 DOI: 10.7759/cureus.13978] [Reference Citation Analysis]
171 Talasaz AH, Sadeghipour P, Kakavand H, Aghakouchakzadeh M, Kordzadeh-Kermani E, Van Tassell BW, Gheymati A, Ariannejad H, Hosseini SH, Jamalkhani S, Sholzberg M, Monreal M, Jimenez D, Piazza G, Parikh SA, Kirtane AJ, Eikelboom JW, Connors JM, Hunt BJ, Konstantinides SV, Cushman M, Weitz JI, Stone GW, Krumholz HM, Lip GYH, Goldhaber SZ, Bikdeli B. Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review. J Am Coll Cardiol 2021;77:1903-21. [PMID: 33741176 DOI: 10.1016/j.jacc.2021.02.035] [Cited by in Crossref: 26] [Cited by in F6Publishing: 77] [Article Influence: 26.0] [Reference Citation Analysis]
172 Sartori M, Cosmi B. Heparin-induced thrombocytopenia and COVID-19. Hematol Rep 2021;13:8857. [PMID: 33747413 DOI: 10.4081/hr.2021.8857] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
173 Finn AP, Khurana RN, Chang LK. Hemi-retinal vein occlusion in a young patient with COVID-19. Am J Ophthalmol Case Rep 2021;22:101046. [PMID: 33688598 DOI: 10.1016/j.ajoc.2021.101046] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
174 Sullivan KD, Galbraith MD, Kinning KT, Bartsch K, Levinsky N, Araya P, Smith KP, Granrath RE, Shaw JR, Baxter R, Jordan KR, Russell S, Dzieciatkowska M, Reisz JA, Gamboni F, Cendali F, Ghosh T, Monte AA, Bennett TD, Miller MG, Hsieh EWY, D'Alessandro A, Hansen KC, Espinosa JM. The COVIDome Explorer Researcher Portal. medRxiv 2021:2021. [PMID: 33758879 DOI: 10.1101/2021.03.04.21252945] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
175 Sollini M, Morbelli S, Ciccarelli M, Cecconi M, Aghemo A, Morelli P, Chiola S, Gelardi F, Chiti A. Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study. Eur J Nucl Med Mol Imaging 2021;48:3187-97. [PMID: 33677642 DOI: 10.1007/s00259-021-05294-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
176 Deinhardt-Emmer S, Böttcher S, Häring C, Giebeler L, Henke A, Zell R, Jungwirth J, Jordan PM, Werz O, Hornung F, Brandt C, Marquet M, Mosig AS, Pletz MW, Schacke M, Rödel J, Heller R, Nietzsche S, Löffler B, Ehrhardt C. SARS-CoV-2 causes severe epithelial inflammation and barrier dysfunction. J Virol 2021:JVI. [PMID: 33637603 DOI: 10.1128/JVI.00110-21] [Cited by in Crossref: 9] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
177 Jha AK, Kulkarni SG. Evolution of COVID-19 management in critical care: review and perspective from a hospital in the United Kingdom. Acute Crit Care 2021;36:1-14. [PMID: 33663036 DOI: 10.4266/acc.2020.00864] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
178 Latil M, Camelo S, Veillet S, Lafont R, Dilda PJ. Developing new drugs that activate the protective arm of the renin-angiotensin system as a potential treatment for respiratory failure in COVID-19 patients. Drug Discov Today 2021;26:1311-8. [PMID: 33609783 DOI: 10.1016/j.drudis.2021.02.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
179 Svensson P, Hofmann R, Häbel H, Jernberg T, Nordberg P. Association between cardiometabolic disease and severe COVID-19: a nationwide case-control study of patients requiring invasive mechanical ventilation. BMJ Open 2021;11:e044486. [PMID: 33597145 DOI: 10.1136/bmjopen-2020-044486] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
180 de Buhr N, von Köckritz-Blickwede M. The Balance of Neutrophil Extracellular Trap Formation and Nuclease Degradation: an Unknown Role of Bacterial Coinfections in COVID-19 Patients? mBio 2021;12:e03304-20. [PMID: 33593982 DOI: 10.1128/mBio.03304-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
181 Longstaff C. Measuring Fibrinolysis. Hamostaseologie 2021;41:69-75. [PMID: 33588458 DOI: 10.1055/a-1325-0268] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
182 Espinoza JAL, Júnior JE, Miranda CH. Atypical COVID-19 presentation with Budd-Chiari syndrome leading to an outbreak in the emergency department. Am J Emerg Med 2021;46:800.e5-7. [PMID: 33573853 DOI: 10.1016/j.ajem.2021.01.090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
183 Dziedzic A, Saluk-Bijak J, Miller E, Niemcewicz M, Bijak M. The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis. Int J Mol Sci 2021;22:1804. [PMID: 33670394 DOI: 10.3390/ijms22041804] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
184 Lang M, Li MD, Jiang KZ, Yoon BC, Mendoza DP, Flores EJ, Rincon SP, Mehan WA Jr, Conklin J, Huang SY, Lang AL, Giao DM, Leslie-Mazwi TM, Kalpathy-Cramer J, Little BP, Buch K. Severity of Chest Imaging is Correlated with Risk of Acute Neuroimaging Findings among Patients with COVID-19. AJNR Am J Neuroradiol 2021;42:831-7. [PMID: 33541897 DOI: 10.3174/ajnr.A7032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
185 Hartmann J, Ergang A, Mason D, Dias JD. The Role of TEG Analysis in Patients with COVID-19-Associated Coagulopathy: A Systematic Review. Diagnostics (Basel) 2021;11:172. [PMID: 33530346 DOI: 10.3390/diagnostics11020172] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 26.0] [Reference Citation Analysis]
186 Eissa M, Abdelhady M, Alqatami H, Salem K, Own A, El Beltagi AH. Spinal cord infarction in a 41-year-old male patient with COVID-19. Neuroradiol J 2021;34:245-8. [PMID: 33480310 DOI: 10.1177/1971400921988925] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
187 Henry BM, Cheruiyot I, Benoit JL, Lippi G, Prohászka Z, Favaloro EJ, Benoit SW. Circulating Levels of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Are Independent Predictors of Coronavirus Disease 2019 Severity: A Prospective, Observational Study. Semin Thromb Hemost 2021;47:451-5. [PMID: 33482678 DOI: 10.1055/s-0040-1722308] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
188 Makowski L, Olson-Sidford W, W-Weisel J. Biological and Clinical Consequences of Integrin Binding via a Rogue RGD Motif in the SARS CoV-2 Spike Protein. Viruses 2021;13:146. [PMID: 33498225 DOI: 10.3390/v13020146] [Cited by in Crossref: 18] [Cited by in F6Publishing: 42] [Article Influence: 18.0] [Reference Citation Analysis]
189 Vojdani A, Vojdani E, Kharrazian D. Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases. Front Immunol 2020;11:617089. [PMID: 33584709 DOI: 10.3389/fimmu.2020.617089] [Cited by in Crossref: 13] [Cited by in F6Publishing: 77] [Article Influence: 13.0] [Reference Citation Analysis]
190 Sanino G, Bosco M, Terrazzano G. Physiology of Midkine and Its Potential Pathophysiological Role in COVID-19. Front Physiol 2020;11:616552. [PMID: 33414726 DOI: 10.3389/fphys.2020.616552] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
191 Marhaeni W, Wijaya AB, Khairiyadi, Munawaroh, Hendriyono. Coagulation Abnormalities Due to COVID-19 in a Child with Thalassemia. Indian J Pediatr 2021;88:396-7. [PMID: 33415546 DOI: 10.1007/s12098-020-03600-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
192 McGonagle D, Bridgewood C, Ramanan AV, Meaney JFM, Watad A. COVID-19 vasculitis and novel vasculitis mimics. Lancet Rheumatol 2021;3:e224-33. [PMID: 33521655 DOI: 10.1016/S2665-9913(20)30420-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 57] [Article Influence: 22.0] [Reference Citation Analysis]
193 Muñoz-Rivas N, Abad-Motos A, Mestre-Gómez B, Sierra-Hidalgo F, Cortina-Camarero C, Lorente-Ramos RM, Torres-Rubio P, Arranz-García P, Franco-Moreno AI, Gómez-Mariscal E, Mauleón-Fernández C, Alonso-García S, Rogado J, Saez-Vaquero T, Such-Diaz A, Ryan P, Moya-Mateo E, Martín-Navarro JA, Hernández-Rivas JA, Torres-Macho J, Churruca J; Infanta Leonor Thrombosis Research Group. Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: A retrospective study. Thromb Res 2021;199:132-42. [PMID: 33503547 DOI: 10.1016/j.thromres.2020.12.024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
194 Trimaille A, Thachil J, Marchandot B, Curtiaud A, Leonard-Lorant I, Carmona A, Matsushita K, Sato C, Sattler L, Grunebaum L, Hansmann Y, Fafi-Kremer S, Jesel L, Ohana M, Morel O. D-Dimers Level as a Possible Marker of Extravascular Fibrinolysis in COVID-19 Patients. J Clin Med 2020;10:E39. [PMID: 33374487 DOI: 10.3390/jcm10010039] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
195 Karmakar D, Lahiri B, Ranjan P, Chatterjee J, Lahiri P, Sengupta S. Road Map to Understanding SARS-CoV-2 Clinico-Immunopathology and COVID-19 Disease Severity. Pathogens 2020;10:5. [PMID: 33374748 DOI: 10.3390/pathogens10010005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
196 Bellos I, Lourida P, Argyraki A, Korompoki E, Zirou C, Kokkinaki I, Pefanis A. Development of a novel risk score for the prediction of critical illness amongst COVID-19 patients. Int J Clin Pract 2021;75:e13915. [PMID: 33969593 DOI: 10.1111/ijcp.13915] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
197 Fang W, Jiang J, Su L, Shu T, Liu H, Lai S, Ghiladi RA, Wang J. The role of NO in COVID-19 and potential therapeutic strategies. Free Radic Biol Med 2021;163:153-62. [PMID: 33347987 DOI: 10.1016/j.freeradbiomed.2020.12.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 43] [Article Influence: 10.5] [Reference Citation Analysis]
198 Higgins V, Sohaei D, Diamandis EP, Prassas I. COVID-19: from an acute to chronic disease? Potential long-term health consequences. Crit Rev Clin Lab Sci 2021;58:297-310. [PMID: 33347790 DOI: 10.1080/10408363.2020.1860895] [Cited by in Crossref: 7] [Cited by in F6Publishing: 69] [Article Influence: 3.5] [Reference Citation Analysis]
199 Seitz R, Gürtler L, Schramm W. Thromboinflammation in COVID-19: Can α2 -macroglobulin help to control the fire? J Thromb Haemost 2021;19:351-4. [PMID: 33230947 DOI: 10.1111/jth.15190] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
200 Aigner L, Pietrantonio F, Bessa de Sousa DM, Michael J, Schuster D, Reitsamer HA, Zerbe H, Studnicka M. The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic. Front Mol Biosci 2020;7:610132. [PMID: 33392263 DOI: 10.3389/fmolb.2020.610132] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
201 Friedrich MS, Studt JD, Braun J, Spahn DR, Kaserer A. Coronavirus-induced coagulopathy during the course of disease. PLoS One 2020;15:e0243409. [PMID: 33332362 DOI: 10.1371/journal.pone.0243409] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
202 Eslamifar Z, Behzadifard M, Soleimani M, Behzadifard S. Coagulation abnormalities in SARS-CoV-2 infection: overexpression tissue factor. Thromb J 2020;18:38. [PMID: 33323111 DOI: 10.1186/s12959-020-00250-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
203 Jain V, Gupta K, Bhatia K, Bansal A, Arora S, Khandelwal AK, Rosenberg JR, Levisay JP, Tommaso CL, Ricciardi MJ, Qamar A. Management of STEMI during the COVID-19 pandemic: Lessons learned in 2020 to prepare for 2021. Trends Cardiovasc Med 2021;31:135-40. [PMID: 33338636 DOI: 10.1016/j.tcm.2020.12.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
204 Marques C, Kakehasi AM, Gomides APM, Paiva EDS, Dos Reis Neto ET, Pileggi GCS, Provenza JR, Mota L, Xavier RM, Ferreira GA, Pinheiro MM. A Brazilian Cohort of Patients With Immuno-Mediated Chronic Inflammatory Diseases Infected by SARS-CoV-2 (ReumaCoV-Brasil Registry): Protocol for a Prospective, Observational Study. JMIR Res Protoc 2020;9:e24357. [PMID: 33156812 DOI: 10.2196/24357] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
205 Rappaport SH, Clark JM, Delibert S, Maynard KM, Prasad P, Kaufman DC, Pietropaoli AP, Quill CM, Groth CM. Anti-FXa Activity with Intermediate-Dose Thromboprophylaxis in COVID-19. Am J Respir Crit Care Med 2020;202:1731-3. [PMID: 32931713 DOI: 10.1164/rccm.202006-2511LE] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
206 Castro-Verdes M, Gkouma A, Wort J, Ridge C, Mirsadraee S, Padley S, Sheikh A, Singh S. Corona Virus Disease 2019 in situ arterial and venous thrombosis in critically ill patients: a case series. Eur Heart J Case Rep 2020;4:1-7. [PMID: 33442596 DOI: 10.1093/ehjcr/ytaa470] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
207 Zakeri A, Jadhav AP, Sullenger BA, Nimjee SM. Ischemic stroke in COVID-19-positive patients: an overview of SARS-CoV-2 and thrombotic mechanisms for the neurointerventionalist. J Neurointerv Surg 2021;13:202-6. [PMID: 33298508 DOI: 10.1136/neurintsurg-2020-016794] [Cited by in Crossref: 14] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
208 Abu-Farha M, Al-Sabah S, Hammad MM, Hebbar P, Channanath AM, John SE, Taher I, Almaeen A, Ghazy A, Mohammad A, Abubaker J, Arefanian H, Al-Mulla F, Thanaraj TA. Prognostic Genetic Markers for Thrombosis in COVID-19 Patients: A Focused Analysis on D-Dimer, Homocysteine and Thromboembolism. Front Pharmacol 2020;11:587451. [PMID: 33362545 DOI: 10.3389/fphar.2020.587451] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
209 Batra A, Clark JR, LaHaye K, Shlobin NA, Hoffman SC, Orban ZS, Colton K, Dematte JE, Sorond FA, Koralnik IJ, Liotta EM. Transcranial Doppler Ultrasound Evidence of Active Cerebral Embolization in COVID-19. J Stroke Cerebrovasc Dis 2021;30:105542. [PMID: 33341023 DOI: 10.1016/j.jstrokecerebrovasdis.2020.105542] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
210 Xu J, Yang X, Huang C, Zou X, Zhou T, Pan S, Yang L, Wu Y, Ouyang Y, Wang Y, Xu D, Zhao X, Shu H, Jiang Y, Xiong W, Ren L, Liu H, Yuan Y, Qi H, Fu S, Chen D, Zhang D, Yuan S, Shang Y. A Novel Risk-Stratification Models of the High-Flow Nasal Cannula Therapy in COVID-19 Patients With Hypoxemic Respiratory Failure. Front Med (Lausanne) 2020;7:607821. [PMID: 33425951 DOI: 10.3389/fmed.2020.607821] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
211 Tsivgoulis G, Palaiodimou L, Zand R, Lioutas VA, Krogias C, Katsanos AH, Shoamanesh A, Sharma VK, Shahjouei S, Baracchini C, Vlachopoulos C, Gournellis R, Sfikakis PP, Sandset EC, Alexandrov AV, Tsiodras S. COVID-19 and cerebrovascular diseases: a comprehensive overview. Ther Adv Neurol Disord 2020;13:1756286420978004. [PMID: 33343709 DOI: 10.1177/1756286420978004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 36] [Article Influence: 9.0] [Reference Citation Analysis]
212 Kruse JM, Magomedov A, Kurreck A, Münch FH, Koerner R, Kamhieh-Milz J, Kahl A, Gotthardt I, Piper SK, Eckardt KU, Dörner T, Zickler D. Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis. Crit Care 2020;24:676. [PMID: 33287877 DOI: 10.1186/s13054-020-03401-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 40] [Article Influence: 7.5] [Reference Citation Analysis]
213 Butt JH, Gerds TA, Schou M, Kragholm K, Phelps M, Havers-Borgersen E, Yafasova A, Gislason GH, Torp-Pedersen C, Køber L, Fosbøl EL. Association between statin use and outcomes in patients with coronavirus disease 2019 (COVID-19): a nationwide cohort study. BMJ Open 2020;10:e044421. [PMID: 33277291 DOI: 10.1136/bmjopen-2020-044421] [Cited by in Crossref: 27] [Cited by in F6Publishing: 38] [Article Influence: 13.5] [Reference Citation Analysis]
214 Brown SA, Zaharova S, Mason P, Thompson J, Thapa B, Ishizawar D, Wilkes E, Ahmed G, Rubenstein J, Sanchez J, Joyce D, Kalyanaraman B, Widlansky M. Pandemic Perspective: Commonalities Between COVID-19 and Cardio-Oncology. Front Cardiovasc Med 2020;7:568720. [PMID: 33344513 DOI: 10.3389/fcvm.2020.568720] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
215 Dhama K, Patel SK, Natesan S, Vora KS, Iqbal Yatoo M, Tiwari R, Saxena SK, Singh KP, Singh R, Malik YS. COVID-19 in the elderly people and advances in vaccination approaches. Hum Vaccin Immunother 2020;16:2938-43. [PMID: 33270497 DOI: 10.1080/21645515.2020.1842683] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
216 Zapor M. Persistent Detection and Infectious Potential of SARS-CoV-2 Virus in Clinical Specimens from COVID-19 Patients. Viruses 2020;12:E1384. [PMID: 33287245 DOI: 10.3390/v12121384] [Cited by in Crossref: 9] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
217 Dugue D, Hsu KT, Wagner IJ, Jones CM. Implications of COVID-19-associated Coagulopathy on Reconstructive Surgery: A Case of Ongoing Tissue Necrosis. Plast Reconstr Surg Glob Open 2020;8:e3366. [PMID: 33425630 DOI: 10.1097/GOX.0000000000003366] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
218 Franchini M, Marano G, Cruciani M, Mengoli C, Pati I, Masiello F, Veropalumbo E, Pupella S, Vaglio S, Liumbruno GM. COVID-19-associated coagulopathy. Diagnosis (Berl) 2020;7:357-63. [PMID: 32683333 DOI: 10.1515/dx-2020-0078] [Cited by in Crossref: 17] [Cited by in F6Publishing: 26] [Article Influence: 8.5] [Reference Citation Analysis]
219 Zhang X, Yang X, Jiao H, Liu X. Coagulopathy in patients with COVID-19: a systematic review and meta-analysis. Aging (Albany NY) 2020;12:24535-51. [PMID: 33229625 DOI: 10.18632/aging.104138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
220 Ortega-Paz L, Capodanno D, Montalescot G, Angiolillo DJ. Coronavirus Disease 2019-Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management. J Am Heart Assoc 2021;10:e019650. [PMID: 33228447 DOI: 10.1161/JAHA.120.019650] [Cited by in Crossref: 22] [Cited by in F6Publishing: 58] [Article Influence: 11.0] [Reference Citation Analysis]
221 Samad N, Sodunke TE, Banna HA, Sapkota A, Fatema AN, Iskandar K, Jahan D, Hardcastle TC, Nusrat T, Chowdhury TS, Haque M. Convalescent Plasma Therapy for Management of COVID-19: Perspectives and Deployment in the Current Global Pandemic. Risk Manag Healthc Policy 2020;13:2707-28. [PMID: 33262668 DOI: 10.2147/RMHP.S281388] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
222 Roshkovan L, Chatterjee N, Galperin-Aizenberg M, Gupta N, Shah R, Barbosa EM Jr, Simpson S, Cook T, Nachiappan A, Knollmann F, Litt H, Desjardins B, Jha S, Panebianco N, Baston C, Thompson JC, Katz SI. The Role of Imaging in the Management of Suspected or Known COVID-19 Pneumonia. A Multidisciplinary Perspective. Ann Am Thorac Soc. 2020;17:1358-1365. [PMID: 33124905 DOI: 10.1513/annalsats.202006-600fr] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
223 Mukaetova-Ladinska EB, Kronenberg G. Psychological and neuropsychiatric implications of COVID-19. Eur Arch Psychiatry Clin Neurosci 2021;271:235-48. [PMID: 33221936 DOI: 10.1007/s00406-020-01210-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
224 Pipe SW, Kaczmarek R, Srivastava A, Pierce GF, Makris M, Hermans C; Interim Guidance., Coagulation Products Safety, Supply and Access (CPSSA) Committee of the World Federation of Hemophilia. Management of COVID-19-associated coagulopathy in persons with haemophilia. Haemophilia 2021;27:41-8. [PMID: 33216448 DOI: 10.1111/hae.14191] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
225 Borazjani R, Seraj SR, Fallahi MJ, Rahmanian Z. Acute portal vein thrombosis secondary to COVID-19: a case report. BMC Gastroenterol 2020;20:386. [PMID: 33213374 DOI: 10.1186/s12876-020-01518-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
226 Kadry R, Newsome AS, Somanath PR. Pharmacological Inhibition of MMP3 as a Potential Therapeutic Option for COVID-19 Associated Acute Respiratory Distress Syndrome. Infect Disord Drug Targets 2021;21:e170721187996. [PMID: 33200717 DOI: 10.2174/1871526520666201116100310] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
227 Zhou L, Huntington K, Zhang S, Carlsen L, So EY, Parker C, Sahin I, Safran H, Kamle S, Lee CM, Geun Lee C, A Elias J, S Campbell K, T Naik M, J Atwood W, Youssef E, A Pachter J, Navaraj A, A Seyhan A, Liang O, El-Deiry WS. MEK inhibitors reduce cellular expression of ACE2, pERK, pRb while stimulating NK-mediated cytotoxicity and attenuating inflammatory cytokines relevant to SARS-CoV-2 infection. Oncotarget 2020;11:4201-23. [PMID: 33245731 DOI: 10.18632/oncotarget.27799] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
228 Kar S, Mottamal M, Al-Horani RA. Discovery of Benzyl Tetraphosphonate Derivative as Inhibitor of Human Factor Xia. ChemistryOpen 2020;9:1161-72. [PMID: 33204588 DOI: 10.1002/open.202000277] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
229 Elkhider H, Ibrahim F, Sharma R, Sheng S, Jasti M, Lotia M, Kapoor N, Onteddu S, Mueed S, Allam H, Nalleballe K. COVID-19 and stroke, a case series and review of literature. Brain Behav Immun Health 2020;9:100172. [PMID: 33173859 DOI: 10.1016/j.bbih.2020.100172] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
230 Lin E, Lantos JE, Strauss SB, Phillips CD, Campion TR Jr, Navi BB, Parikh NS, Merkler AE, Mir S, Zhang C, Kamel H, Cusick M, Goyal P, Gupta A. Brain Imaging of Patients with COVID-19: Findings at an Academic Institution during the Height of the Outbreak in New York City. AJNR Am J Neuroradiol 2020;41:2001-8. [PMID: 32819899 DOI: 10.3174/ajnr.A6793] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 23.0] [Reference Citation Analysis]
231 Ghafouri S, Rettig M, Kahlon KS. An 89-Year-Old Man with COVID-19-Associated Coagulopathy Presenting with a Prolonged Partial Thromboplastin Time, Lupus Anticoagulant, and a High Titer of Factor VIII Inhibitor. Am J Case Rep 2020;21:e926728. [PMID: 33122620 DOI: 10.12659/AJCR.926728] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
232 Sollini M, Ciccarelli M, Cecconi M, Aghemo A, Morelli P, Gelardi F, Chiti A. Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study. Eur J Nucl Med Mol Imaging 2021;48:1460-6. [PMID: 33123760 DOI: 10.1007/s00259-020-05084-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 48] [Article Influence: 9.5] [Reference Citation Analysis]
233 Kichloo A, Dettloff K, Aljadah M, Albosta M, Jamal S, Singh J, Wani F, Kumar A, Vallabhaneni S, Khan MZ. COVID-19 and Hypercoagulability: A Review. Clin Appl Thromb Hemost 2020;26:1076029620962853. [PMID: 33074732 DOI: 10.1177/1076029620962853] [Cited by in Crossref: 11] [Cited by in F6Publishing: 38] [Article Influence: 5.5] [Reference Citation Analysis]
234 Medicherla CB, Pauley RA, de Havenon A, Yaghi S, Ishida K, Torres JL. Cerebral Venous Sinus Thrombosis in the COVID-19 Pandemic. J Neuroophthalmol 2020;40:457-62. [PMID: 33186264 DOI: 10.1097/WNO.0000000000001122] [Cited by in Crossref: 11] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
235 Cárdenas G, Torres-García D, Cervantes-Torres J, Rosales-Mendoza S, Fleury A, Fragoso G, Laclette JP, Sciutto E. Role of Systemic and Nasal Glucocorticoid Treatment in the Regulation of the Inflammatory Response in Patients with SARS-Cov-2 Infection. Arch Med Res 2021;52:143-50. [PMID: 33160751 DOI: 10.1016/j.arcmed.2020.10.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
236 Fan BE, Ng J, Chan SSW, Christopher D, Tso ACY, Ling LM, Young BE, Wong LJL, Sum CLL, Tan HT, Ang MK, Lim GH, Ong KH, Kuperan P, Chia YW. COVID-19 associated coagulopathy in critically ill patients: A hypercoagulable state demonstrated by parameters of haemostasis and clot waveform analysis. J Thromb Thrombolysis 2021;51:663-74. [PMID: 33098540 DOI: 10.1007/s11239-020-02318-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
237 Parsons N, Outsikas A, Parish A, Clohesy R, Thakkar N, D'Aprano F, Toomey F, Advani S, Poudel G. Modelling the Anatomical Distribution of Neurological Events in COVID-19 Patients: A Systematic Review. medRxiv 2020:2020. [PMID: 33106811 DOI: 10.1101/2020.10.21.20215640] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
238 Pavlov V, Beylerli O, Gareev I, Torres Solis LF, Solís Herrera A, Aliev G. COVID-19-Related Intracerebral Hemorrhage. Front Aging Neurosci 2020;12:600172. [PMID: 33192492 DOI: 10.3389/fnagi.2020.600172] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
239 Gąsecka A, Borovac JA, Guerreiro RA, Giustozzi M, Parker W, Caldeira D, Chiva-Blanch G. Thrombotic Complications in Patients with COVID-19: Pathophysiological Mechanisms, Diagnosis, and Treatment. Cardiovasc Drugs Ther 2021;35:215-29. [PMID: 33074525 DOI: 10.1007/s10557-020-07084-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 46] [Article Influence: 16.5] [Reference Citation Analysis]
240 Haynes BF, Corey L, Fernandes P, Gilbert PB, Hotez PJ, Rao S, Santos MR, Schuitemaker H, Watson M, Arvin A. Prospects for a safe COVID-19 vaccine. Sci Transl Med 2020;12:eabe0948. [PMID: 33077678 DOI: 10.1126/scitranslmed.abe0948] [Cited by in Crossref: 77] [Cited by in F6Publishing: 101] [Article Influence: 38.5] [Reference Citation Analysis]
241 Cappellari M, Zini A, Sangalli D, Cavallini A, Reggiani M, Sepe FN, Rifino N, Giussani G, Guidetti D, Zedde M, Marcheselli S, Longoni M, Beretta S, Sidoti V, Papurello DM, Giossi A, Nencini P, Plocco M, Balestrino M, Rota E, Toni D. Thrombolysis and bridging therapy in patients with acute ischaemic stroke and Covid-19. Eur J Neurol 2020;27:2641-5. [PMID: 32905639 DOI: 10.1111/ene.14511] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
242 Chang JC. Disseminated intravascular coagulation: new identity as endotheliopathy-associated vascular microthrombotic disease based on in vivo hemostasis and endothelial molecular pathogenesis. Thromb J 2020;18:25. [PMID: 33061857 DOI: 10.1186/s12959-020-00231-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
243 Becker RC. Anticipating the long-term cardiovascular effects of COVID-19. J Thromb Thrombolysis 2020;50:512-24. [PMID: 32880795 DOI: 10.1007/s11239-020-02266-6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 43] [Article Influence: 15.5] [Reference Citation Analysis]
244 Azar MM, Shin JJ, Kang I, Landry M. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome. Expert Rev Mol Diagn 2020;20:1087-97. [PMID: 32990479 DOI: 10.1080/14737159.2020.1830760] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
245 Overmyer KA, Shishkova E, Miller IJ, Balnis J, Bernstein MN, Peters-Clarke TM, Meyer JG, Quan Q, Muehlbauer LK, Trujillo EA, He Y, Chopra A, Chieng HC, Tiwari A, Judson MA, Paulson B, Brademan DR, Zhu Y, Serrano LR, Linke V, Drake LA, Adam AP, Schwartz BS, Singer HA, Swanson S, Mosher DF, Stewart R, Coon JJ, Jaitovich A. Large-Scale Multi-omic Analysis of COVID-19 Severity. Cell Syst 2021;12:23-40.e7. [PMID: 33096026 DOI: 10.1016/j.cels.2020.10.003] [Cited by in Crossref: 90] [Cited by in F6Publishing: 169] [Article Influence: 45.0] [Reference Citation Analysis]
246 Muniangi-Muhitu H, Akalestou E, Salem V, Misra S, Oliver NS, Rutter GA. Covid-19 and Diabetes: A Complex Bidirectional Relationship. Front Endocrinol (Lausanne). 2020;11:582936. [PMID: 33133024 DOI: 10.3389/fendo.2020.582936] [Cited by in Crossref: 23] [Cited by in F6Publishing: 31] [Article Influence: 11.5] [Reference Citation Analysis]
247 Willows S, Alam SB, Sandhu JK, Kulka M. A Canadian perspective on severe acute respiratory syndrome coronavirus 2 infection and treatment: how prevalent underlying inflammatory disease contributes to pathogenesis. Biochem Cell Biol 2021;99:173-94. [PMID: 33027600 DOI: 10.1139/bcb-2020-0341] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
248 Thompson S, Bohn MK, Mancini N, Loh TP, Wang CB, Grimmler M, Yuen KY, Mueller R, Koch D, Sethi S, Rawlinson WD, Clementi M, Erasmus R, Leportier M, Kwon GC, Menezes ME, Patru MM, Gramegna M, Singh K, Najjar O, Ferrari M, Lippi G, Adeli K, Horvath AR; IFCC Taskforce on COVID-19. IFCC Interim Guidelines on Biochemical/Hematological Monitoring of COVID-19 Patients. Clin Chem Lab Med 2020;58:2009-16. [PMID: 33027044 DOI: 10.1515/cclm-2020-1414] [Cited by in Crossref: 10] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
249 Mokhtari T, Hassani F, Ghaffari N, Ebrahimi B, Yarahmadi A, Hassanzadeh G. COVID-19 and multiorgan failure: A narrative review on potential mechanisms. J Mol Histol. 2020;51:613-628. [PMID: 33011887 DOI: 10.1007/s10735-020-09915-3] [Cited by in Crossref: 61] [Cited by in F6Publishing: 134] [Article Influence: 30.5] [Reference Citation Analysis]
250 Kosmeri C, Koumpis E, Tsabouri S, Siomou E, Makis A. Hematological manifestations of SARS-CoV-2 in children. Pediatr Blood Cancer 2020;67:e28745. [PMID: 33009893 DOI: 10.1002/pbc.28745] [Cited by in Crossref: 14] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
251 Flumignan RL, Tinôco JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah ÁN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev 2020;10:CD013739. [PMID: 33502773 DOI: 10.1002/14651858.CD013739] [Cited by in Crossref: 11] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
252 Becker RC. COVID-19-associated vasculitis and vasculopathy. J Thromb Thrombolysis 2020;50:499-511. [PMID: 32700024 DOI: 10.1007/s11239-020-02230-4] [Cited by in Crossref: 77] [Cited by in F6Publishing: 110] [Article Influence: 38.5] [Reference Citation Analysis]
253 Weber AG, Chau AS, Egeblad M, Barnes BJ, Janowitz T. Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: a case series. Mol Med 2020;26:91. [PMID: 32993479 DOI: 10.1186/s10020-020-00215-w] [Cited by in Crossref: 17] [Cited by in F6Publishing: 39] [Article Influence: 8.5] [Reference Citation Analysis]
254 Cadegiani FA. Repurposing existing drugs for COVID-19: an endocrinology perspective. BMC Endocr Disord 2020;20:149. [PMID: 32993622 DOI: 10.1186/s12902-020-00626-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 14.0] [Reference Citation Analysis]
255 Szegedi I, Orbán-Kálmándi R, Csiba L, Bagoly Z. Stroke as a Potential Complication of COVID-19-Associated Coagulopathy: A Narrative and Systematic Review of the Literature. J Clin Med 2020;9:E3137. [PMID: 32998398 DOI: 10.3390/jcm9103137] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
256 Rahman A, Niloofa R, De Zoysa IM, Cooray AD, Kariyawasam J, Seneviratne SL. Neurological manifestations in COVID-19: A narrative review. SAGE Open Med 2020;8:2050312120957925. [PMID: 32974019 DOI: 10.1177/2050312120957925] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
257 Bordallo B, Bellas M, Cortez AF, Vieira M, Pinheiro M. Severe COVID-19: what have we learned with the immunopathogenesis? Adv Rheumatol 2020;60:50. [PMID: 32962761 DOI: 10.1186/s42358-020-00151-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 1] [Article Influence: 11.5] [Reference Citation Analysis]
258 Bordallo B, Bellas M, Cortez AF, Vieira M, Pinheiro M. Severe COVID-19: what have we learned with the immunopathogenesis? Adv Rheumatol 2020;60:50. [PMID: 32962761 DOI: 10.1186/s42358-020-00151-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
259 Amouri J, Andrews PS, Heckers S, Ely EW, Wilson JE. A Case of Concurrent Delirium and Catatonia in a Woman With Coronavirus Disease 2019. J Acad Consult Liaison Psychiatry 2021;62:109-14. [PMID: 33069380 DOI: 10.1016/j.psym.2020.09.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
260 Soumya RS, Unni TG, Raghu KG. Impact of COVID-19 on the Cardiovascular System: A Review of Available Reports. Cardiovasc Drugs Ther 2021;35:411-25. [PMID: 32926272 DOI: 10.1007/s10557-020-07073-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
261 Mudatsir M, Fajar JK, Wulandari L, Soegiarto G, Ilmawan M, Purnamasari Y, Mahdi BA, Jayanto GD, Suhendra S, Setianingsih YA, Hamdani R, Suseno DA, Agustina K, Naim HY, Muchlas M, Alluza HHD, Rosida NA, Mayasari M, Mustofa M, Hartono A, Aditya R, Prastiwi F, Meku FX, Sitio M, Azmy A, Santoso AS, Nugroho RA, Gersom C, Rabaan AA, Masyeni S, Nainu F, Wagner AL, Dhama K, Harapan H. Predictors of COVID-19 severity: a systematic review and meta-analysis. F1000Res 2020;9:1107. [PMID: 33163160 DOI: 10.12688/f1000research.26186.2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
262 Mudatsir M, Fajar JK, Wulandari L, Soegiarto G, Ilmawan M, Purnamasari Y, Mahdi BA, Jayanto GD, Suhendra S, Setianingsih YA, Hamdani R, Suseno DA, Agustina K, Naim HY, Muchlas M, Alluza HHD, Rosida NA, Mayasari M, Mustofa M, Hartono A, Aditya R, Prastiwi F, Meku FX, Sitio M, Azmy A, Santoso AS, Nugroho RA, Gersom C, Rabaan AA, Masyeni S, Nainu F, Wagner AL, Dhama K, Harapan H. Predictors of COVID-19 severity: a systematic review and meta-analysis. F1000Res 2020;9:1107. [PMID: 33163160 DOI: 10.12688/f1000research.26186.2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 16.0] [Reference Citation Analysis]
263 Fan BE, Chang CCR, Teo CHY, Yap ES. COVID-19 Coagulopathy with Superior Mesenteric Vein Thrombosis Complicated by an Ischaemic Bowel. Hamostaseologie 2020;40:592-3. [PMID: 32894875 DOI: 10.1055/a-1232-7446] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
264 Amgalan A, Malinowski AK, Othman M. COVID-19 and Sex-/Gender-Specific Differences: Understanding the Discrimination. Semin Thromb Hemost 2021;47:341-7. [PMID: 32882714 DOI: 10.1055/s-0040-1715455] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
265 Barry TWL, Jeanette TSLJ, Ashokka B, Lopez KG, Thambiah J, Kumar N. In the Extraordinary Times of Coronavirus Disease 2019: Clinical Strategies for Performing Spinal Surgery. Asian Spine J 2020;14:721-9. [PMID: 32872763 DOI: 10.31616/asj.2020.0306] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
266 Zhou L, Huntington K, Zhang S, Carlsen L, So EY, Parker C, Sahin I, Safran H, Kamle S, Lee CM, Lee CG, Elias JA, Campbell KS, Naik MT, Atwood WJ, Youssef E, Pachter JA, Navaraj A, Seyhan AA, Liang O, El-Deiry WS. Natural Killer cell activation, reduced ACE2, TMPRSS2, cytokines G-CSF, M-CSF and SARS-CoV-2-S pseudovirus infectivity by MEK inhibitor treatment of human cells. bioRxiv 2020:2020. [PMID: 32793908 DOI: 10.1101/2020.08.02.230839] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
267 Atri A, Kocherlakota CM, Dasgupta R. Managing diabetic foot in times of COVID-19: time to put the best 'foot' forward. Int J Diabetes Dev Ctries 2020;:1-8. [PMID: 32904959 DOI: 10.1007/s13410-020-00866-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
268 Veerabathini BC, Manthani K, Gandhi S. An Unusual Case of Moraxella osleonsis Bacteremia in an Immunocompetent Patient With SARS-CoV-2 Infection. Cureus 2020;12:e10154. [PMID: 32884878 DOI: 10.7759/cureus.10154] [Reference Citation Analysis]
269 Zhang Z, Xi L, Zhang S, Zhang Y, Pang W, Wang Y, Li C, Zhai Z, Wang C. Awareness and Prophylaxis of Venous Thromboembolism in Patients with COVID-19: A National Cross-Sectional Survey in Epidemic Era. J Atheroscler Thromb 2020;27:1123-37. [PMID: 32863290 DOI: 10.5551/jat.58933] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
270 Robb CT, Goepp M, Rossi AG, Yao C. Non-steroidal anti-inflammatory drugs, prostaglandins, and COVID-19. Br J Pharmacol 2020;177:4899-920. [PMID: 32700336 DOI: 10.1111/bph.15206] [Cited by in Crossref: 21] [Cited by in F6Publishing: 35] [Article Influence: 10.5] [Reference Citation Analysis]
271 Laine RA. The case for re-examining glycosylation inhibitors, mimetics, primers and glycosylation decoys as antivirals and anti-inflammatories in COVID19. Glycobiology 2020;30:763-7. [PMID: 32829416 DOI: 10.1093/glycob/cwaa083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
272 Chatterjee S, Sengupta T, Majumder S, Majumder R. COVID-19: a probable role of the anticoagulant Protein S in managing COVID-19-associated coagulopathy. Aging (Albany NY) 2020;12:15954-61. [PMID: 32826388 DOI: 10.18632/aging.103869] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
273 Janardhan V, Janardhan V, Kalousek V. COVID-19 as a Blood Clotting Disorder Masquerading as a Respiratory Illness: A Cerebrovascular Perspective and Therapeutic Implications for Stroke Thrombectomy. J Neuroimaging 2020;30:555-61. [PMID: 32776617 DOI: 10.1111/jon.12770] [Cited by in Crossref: 13] [Cited by in F6Publishing: 21] [Article Influence: 6.5] [Reference Citation Analysis]
274 Cattrini C, Bersanelli M, Latocca MM, Conte B, Vallome G, Boccardo F. Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer. Cancers (Basel) 2020;12:E2325. [PMID: 32824674 DOI: 10.3390/cancers12082325] [Cited by in Crossref: 23] [Cited by in F6Publishing: 37] [Article Influence: 11.5] [Reference Citation Analysis]
275 Baindara P, Agrawal S, Mandal SM. Host-directed therapies: a potential solution to combat COVID-19. Expert Opin Biol Ther 2020;20:1117-20. [PMID: 32783643 DOI: 10.1080/14712598.2020.1807001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
276 Funk CD, Ardakani A. A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes. Front Pharmacol 2020;11:1214. [PMID: 32848802 DOI: 10.3389/fphar.2020.01214] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
277 Esakandari H, Nabi-Afjadi M, Fakkari-Afjadi J, Farahmandian N, Miresmaeili SM, Bahreini E. A comprehensive review of COVID-19 characteristics. Biol Proced Online 2020;22:19. [PMID: 32774178 DOI: 10.1186/s12575-020-00128-2] [Cited by in Crossref: 74] [Cited by in F6Publishing: 138] [Article Influence: 37.0] [Reference Citation Analysis]
278 Patel P, Sengupta N. PPIs and Beyond: A Framework for Managing Anticoagulation-Related Gastrointestinal Bleeding in the Era of COVID-19. Dig Dis Sci 2020;65:2181-6. [PMID: 32537704 DOI: 10.1007/s10620-020-06408-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
279 Nuche J, Segura de la Cal T, Jiménez López Guarch C, López-Medrano F, Delgado CP, Ynsaurriaga FA, Delgado JF, Ibáñez B, Oliver E, Subías PE. Effect of Coronavirus Disease 2019 in Pulmonary Circulation. The Particular Scenario of Precapillary Pulmonary Hypertension. Diagnostics (Basel) 2020;10:E548. [PMID: 32752129 DOI: 10.3390/diagnostics10080548] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
280 Insausti-García A, Reche-Sainz JA, Ruiz-Arranz C, López Vázquez Á, Ferro-Osuna M. Papillophlebitis in a COVID-19 patient: Inflammation and hypercoagulable state. Eur J Ophthalmol 2020;:1120672120947591. [PMID: 32735134 DOI: 10.1177/1120672120947591] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 13.5] [Reference Citation Analysis]
281 Huertas A, Montani D, Savale L, Pichon J, Tu L, Parent F, Guignabert C, Humbert M. Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)? Eur Respir J 2020;56:2001634. [PMID: 32554538 DOI: 10.1183/13993003.01634-2020] [Cited by in Crossref: 108] [Cited by in F6Publishing: 159] [Article Influence: 54.0] [Reference Citation Analysis]
282 Fan BE, Chia YW, Sum CLL, Kuperan P, Chan SSW, Ling LM, Tan GWL, Goh SSN, Wong LH, Lim SP, Lim KGE, Tan HT, Ang MK, Lau SL, Ong KH, Ng J. Global haemostatic tests in rapid diagnosis and management of COVID-19 associated coagulopathy in acute limb ischaemia. J Thromb Thrombolysis 2020;50:292-7. [PMID: 32474758 DOI: 10.1007/s11239-020-02165-w] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
283 Overmyer KA, Shishkova E, Miller IJ, Balnis J, Bernstein MN, Peters-Clarke TM, Meyer JG, Quan Q, Muehlbauer LK, Trujillo EA, He Y, Chopra A, Chieng HC, Tiwari A, Judson MA, Paulson B, Brademan DR, Zhu Y, Serrano LR, Linke V, Drake LA, Adam AP, Schwartz BS, Singer HA, Swanson S, Mosher DF, Stewart R, Coon JJ, Jaitovich A. Large-scale Multi-omic Analysis of COVID-19 Severity. medRxiv 2020:2020. [PMID: 32743614 DOI: 10.1101/2020.07.17.20156513] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 5.5] [Reference Citation Analysis]
284 Khalil S, Hinds BR, Manalo IF, Vargas IM, Mallela S, Jacobs R. Livedo reticularis as a presenting sign of severe acute respiratory syndrome coronavirus 2 infection. JAAD Case Rep 2020;6:871-4. [PMID: 32835045 DOI: 10.1016/j.jdcr.2020.07.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
285 de Vries AAF. SARS-CoV-2/COVID-19: a primer for cardiologists. Neth Heart J 2020;28:366-83. [PMID: 32671650 DOI: 10.1007/s12471-020-01475-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
286 Momtazmanesh S, Shobeiri P, Hanaei S, Mahmoud-Elsayed H, Dalvi B, Malakan Rad E. Cardiovascular disease in COVID-19: a systematic review and meta-analysis of 10,898 patients and proposal of a triage risk stratification tool. Egypt Heart J 2020;72:41. [PMID: 32661796 DOI: 10.1186/s43044-020-00075-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
287 Mackman N, Antoniak S, Wolberg AS, Kasthuri R, Key NS. Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses. Arterioscler Thromb Vasc Biol 2020;40:2033-44. [PMID: 32657623 DOI: 10.1161/ATVBAHA.120.314514] [Cited by in Crossref: 47] [Cited by in F6Publishing: 83] [Article Influence: 23.5] [Reference Citation Analysis]
288 Garg RK, Paliwal VK, Gupta A. Encephalopathy in patients with COVID-19: A review. J Med Virol. 2021;93:206-222. [PMID: 32558956 DOI: 10.1002/jmv.26207] [Cited by in Crossref: 47] [Cited by in F6Publishing: 75] [Article Influence: 23.5] [Reference Citation Analysis]
289 Marietta M, Coluccio V, Luppi M. COVID-19, coagulopathy and venous thromboembolism: more questions than answers. Intern Emerg Med 2020;15:1375-87. [PMID: 32653981 DOI: 10.1007/s11739-020-02432-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 45] [Article Influence: 16.5] [Reference Citation Analysis]
290 Ahmed S, Zimba O, Gasparyan AY. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad. Clin Rheumatol. 2020;39:2529-2543. [PMID: 32654082 DOI: 10.1007/s10067-020-05275-1] [Cited by in Crossref: 62] [Cited by in F6Publishing: 95] [Article Influence: 31.0] [Reference Citation Analysis]
291 Choudhury I, Han H, Manthani K, Gandhi S, Dabhi R. COVID-19 as a Possible Cause of Functional Exhaustion of CD4 and CD8 T-cells and Persistent Cause of Methicillin-Sensitive Staphylococcus aureus Bacteremia. Cureus 2020;12:e9000. [PMID: 32775080 DOI: 10.7759/cureus.9000] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
292 Park JF, Banerjee S, Umar S. In the eye of the storm: the right ventricle in COVID-19. Pulm Circ 2020;10:2045894020936660. [PMID: 32655856 DOI: 10.1177/2045894020936660] [Cited by in Crossref: 16] [Cited by in F6Publishing: 38] [Article Influence: 8.0] [Reference Citation Analysis]
293 Siripanthong B, Hanff TC, Levin MG, Vidula MK, Khanji MY, Nazarian S, Chahal CAA. Coronavirus disease 2019 is delaying the diagnosis and management of chest pain, acute coronary syndromes, myocarditis and heart failure. Future Cardiol 2021;17:3-6. [PMID: 32608242 DOI: 10.2217/fca-2020-0088] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
294 Lobastov KV, Schastlivtsev IV, Porembskaya OY, Dzenina OV, Bargandzhiya AB, Tsaplin SN. COVID-19-associated coagulopathy: review of current recommendations for diagnosis, treatment and prevention. Ambulatornaya khirurgiya 2020. [DOI: 10.21518/1995-1477-2020-3-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
295 Ribes A, Vardon-Bounes F, Mémier V, Poette M, Au-Duong J, Garcia C, Minville V, Sié P, Bura-Rivière A, Voisin S, Payrastre B. Thromboembolic events and Covid-19. Adv Biol Regul 2020;77:100735. [PMID: 32773098 DOI: 10.1016/j.jbior.2020.100735] [Cited by in Crossref: 21] [Cited by in F6Publishing: 37] [Article Influence: 10.5] [Reference Citation Analysis]
296 Putilina M, Vechorko V, Grishin D, Sidelnikova L. Acute cerebrovascular accidents associated with SARS-CoV-2 coronavirus infection (COVID-19). Z nevrol psikhiatr im S S Korsakova 2020;120:109. [DOI: 10.17116/jnevro2020120121109] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
297 I. Abdullah IA, Z.c. Chapanduka ZC. The pathophysiology of the haematological manifestations of COVID-19 : a review. The Journal of Medical Laboratory Science and Technology of South Africa 2020;2:54-8. [DOI: 10.36303/jmlstsa.2020.2.2.48] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
298 Putilina M, Grishin D. SARS-CoV-2 (COVID-19) as a predictor of neuroinflammation and neurodegeneration: potential therapy strategies. Z nevrol psikhiatr im S S Korsakova 2020;120:58. [DOI: 10.17116/jnevro202012008258] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
299 Scheim D. From Cold to Killer: How SARS-CoV-2 Evolved without Hemagglutinin Esterase to Agglutinate, Then Clot Blood Cells in Pulmonary and Systemic Microvasculature. SSRN Journal. [DOI: 10.2139/ssrn.3706347] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
300 [DOI: 10.1101/2021.01.04.21249227] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
301 [DOI: 10.1101/2020.05.11.088500] [Cited by in Crossref: 35] [Cited by in F6Publishing: 12] [Reference Citation Analysis]